To easily search for a policy, use the Ctrl+F (Command+F on Mac) function on your keyboard to search by keyword, policy number or effective date. 

What are Clinical Policies?

Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include policies relating to evolving medical technologies and procedures as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice, including peer-reviewed medical literature, government agency/program approval status, evidence-based guidelines, positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas affected by the policy, and other available clinical information.

All policies found on the QualChoice Clinical Policy page apply to QualChoice members. Policies on this QualChoice page may have either a “QualChoice” or a “Centene” heading. QualChoice follows care guidelines published by InterQual.
QualChoice may, from time to time, delegate utilization management of specific services. In such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in the policies on this page or within the InterQual criteria is payable by QualChoice.

QualChoice reserves the right to alter, amend, change or supplement medical policies as needed. QualChoice reviews and authorizes services and substances. CPT and HCPCS codes are listed as a convenience and any absent, new or changed codes do not alter the intent of the policy.

What are Payment Policies?

Healthcare claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether healthcare services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include claims processing guidelines referenced by the Centers for Medicare & Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), CPT® guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of healthcare and medical necessity, ClaimsXten™ review, and, at times, state-specific claims reimbursement guidance. More information about ClaimsXten and the way we utilize ClaimsXten with relation to claims payments can be found on our Claims and Payment Information page.

All policies found on this page apply with respect to QualChoice members. These payment policies may have either a “QualChoice” or a “Centene” heading. QualChoice may, from time-to-time, employ a vendor that applies payment policies to specific services. In such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in these policies is payable by QualChoice.

Clinical Policies for CT/CTA/CCTA, MRI, MRA, and Pet scans can also be found at the Evolent website.

   
Policy Title Policy Number Effective Date
25-hydroxyvitamin D Testing in Children and Adolescents (PDF) CP.MP.157 November 1, 2024
Air Ambulance (PDF) CP.MP.175 May 1, 2025
Ambulance Services (PDF) QCP.CP.045 May 1, 2024
Allergy Testing & Treatment (PDF) CP.MP.100 November 1, 2024
Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (PDF) CP.MP.108 October 1, 2024
Alternative or Complementary Healing (PDF) QCP.CP.018 May 1, 2024
Assisted Reproductive Technology (PDF) CP.MP.55 July 1, 2025
Attention Deficit Hyperactivity Disorder Assessment and Treatment (PDF) CP.BH.124 May 1, 2024
Bariatric Surgery: Federal Employees Health Benefits (PDF) QCP.CP.029 May 1, 2024
Behavioral Health Treatment Documentation Requirements (PDF) CP.BH.500 July 1, 2024
Biofeedback (PDF) CP.MP.168 February 1, 2025
Biofeedback for Behavioral Health Disorders (PDF) CP.BH.300 January 1, 2025
Bone-Anchored Hearing Aids (PDF) AR.CP.MP.93 January 1, 2025
Burn Surgery (PDF) CP.MP.186 February 1, 2025
Cardiac Biomarker Testing (PDF) CP.MP.156 November 1, 2024
Caudal or Interlaminar Epidural Steroid Injections (PDF) CP.MP.164 August 1, 2024
Clinical Trials (PDF) CP.MP.94 August 1, 2024
Cochlear Implanted Replacements (PDF) AR.CP.MP.14 September 1, 2024
V1.2025 - CG Oncology: Algorithmic Testing (PDF) V1.2025 April 1, 2025
V1.2025 - CG Oncology: Cancer Screening AR Specific Version (PDF) V1.2025  April 1, 2025
V1.2025 - CG Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (PDF) V1.2025 April 1, 2025
V1.2025 - CG Oncology: Cytogenetic Testing (PDF) V1.2025 April 1, 2025
V1.2025 - CG Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Aortopathies and Connective Tissue Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Cardiac Disorders (PDF) V1.2025  April 1, 2025
V1.2025 - CG Testing: Dermatologic Conditions (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (PDF) V1.2025  April 1, 2025
V1.2025 - CG Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF) V1.2025   April 1, 2025
V1.2025 - CG Testing: Eye Disorders (PDF) V1.2025   April 1, 2025
V1.2025 - CG Testing: Gastroenterologic Disorders Non-Cancerous (PDF) V1.2025   April 1, 2025
V1.2025 - CG Testing: General Approach to Genetic and Molecular Testing (PDF) V1.2025  April 1, 2025
V1.2025 - CG Testing: Hearing Loss (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Hematologic Conditions Non-Cancerous (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Hereditary Cancer Susceptibility (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Kidney Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Lung Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Prenatal Cell-Free DNA Testing (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Pharmacogenetics (Version B) (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Preimplantation Genetic Testing (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Prenatal and Preconception Carrier Screening (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF) V1.2025 April 1, 2025
Continuous Glucose Monitors AR.QC.PMN.214 January 1, 2025
Corneal Remodeling (f.n.a. Refractive Surgical Procedures) (PDF) QCP.CP.021 May 1, 2024
Corneal Topography (PDF) QCP.CP.022 May 1, 2024
Cosmetic and Reconstructive Procedures (PDF) CP.MP.31 October 1, 2024
Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder (PDF) CP.BH.201 August 1, 2024
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF) CP.PCH.56 July 15, 2025
Diaphragmatic/Phrenic Nerve Stimulation (PDF) CP.MP.203 September 1, 2024
Digital EEG Spike Analysis (PDF) CP.MP.105 November 1, 2024
Disc Decompression Procedures (PDF) CP.MP.114 October 1, 2024
Discography (PDF) CP.MP.115 July 1, 2024
Donor Lymphocyte Infusion (PDF) CP.MP.101 April 1, 2025
Drugs of Abuse, Definitive Testing (PDF) CP.MP.50 May 1, 2025
Durable Medical Equipment and Orthotics Guidelines (PDF) AR.CP.MP.107 May 1, 2025
EED in the Evaluation of Headache (PDF) CP.MP.155 November 1, 2024
Electric Tumor Treating Fields (Optune) (PDF) CP.MP.145 March 1, 2025
Endometrial Ablation (PDF) CP.MP.106 November 1, 2024
Evoked Potential Testing (PDF) CP.MP.134 November 1, 2024
Experimental Technologies (PDF) CP.MP.36 June 1, 2024
Facet Joint Interventions (PDF) CP.MP.171 November 1, 2024
Facility-based Sleep Studies for Obstructive Sleep Apnea (PDF) CP.MP.248 March 1, 2025
Fecal Incontinence Treatments (PDF) CP.MP.137 August 1, 2024
FEHB Fertility Preservation (PDF) QCP.CP.042 May 1, 2024
FEHBP Gender Reassignment Surgery (PDF) QCP.CP.037 May 1, 2024
FEHB Infertility Coverage (PDF) QCP.CP.027 May 1, 2024
Fetal Surgery in Utero for Prenatally Diagnosed Malformations (PDF) CP.MP.129 November 1, 2024
Ferriscan R2-MRI (PDF) CP.MP.53 May 1, 2024
Gastric Electrical Stimulation (PDF) CP.MP.40 May 1, 2024
Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (PDF) CP.MP.209 May 1, 2024
Gender Affirming Procedures (PDF) CP.MP.95 September 1, 2024
H. Pylori Serology Testing (PDF) CP.MP.153 November 1, 2024
Habilitative Services (PDF) QCP.CP.035 May 1, 2024
Heart-Lung Transplant (PDF) CP.MP.132 May 1, 2024
Holter Monitors (PDF) CP.MP.113 May 1, 2025
Home Ventilators (PDF) CP.MP.184 May 1, 2025
Homocysteine Testing (PDF) CP.MP.121 May 1, 2025
Hospice Services (PDF) CP.MP.54 November 1, 2024
Hyperhidrosis Treatments (PDF) CP.MP.62 May 1, 2025
Hypnotherapy (PDF) QCP.CP.014 May 1, 2024
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea (PDF) CP.MP.180 May 1, 2025
Implantable Intrathecal or Epidural Pain Pump (PDF) CP.MP.173 February 1, 2025
Implantable Loop Recorder (PDF) CP.MP.243 February 1, 2025
Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF) CP.MP.160 April 1, 2025
Infertility Diagnosis and Treatment (PDF) QCP.CP.015 May 1, 2024
Intensity-Modulated Radiotherapy (PDF) CP.MP.69 September 1, 2024
Intestinal and Multivisceral Transplant (PDF) CP.MP.58 July 1, 2024
Intradiscal Steroid Injections for Pain Management (PDF) CP.MP.167 September 1, 2024
Intraoperative Neurophysiological Monitoring (PDF) QCP.CP.033 May 1, 2024
IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (PDF) CP.MP.61 October 1, 2024
Lantidra (donislecel) Allogenic Pancreatic Islet Cellular Therapy (PDF) CP.MP.250 September 1, 2024
Liposuction for Lipedema (PDF) CP.MP.244 July 1, 2024
Lung Transplantation (PDF) CP.MP.57 June 1, 2024
Lysis of Epidural Lesions (PDF) CP.MP.116 July 1, 2024
Measurement of Serum 1,25-dihydroxyvitamin D (PDF) CP.MP.152 November 1, 2024
Mechanical Stretch devices for joint stiffness or contractures (PDF) CP.MP.144 May 1, 2025
Medical Services that Require Dental Services (PDF) QCP.CP.030 May 1, 2024
Multiple Sleep Latency Testing (PDF) CP.MP.24 July 1, 2024
Neonatal Abstinence Syndrome Guidelines (PDF) CP.MP.86 May 1, 2024
Neonatal Sepsis Management (PDF) CP.MP.85 May 1, 2024
Nerve Blocks for Pain Management (PDF) CP.MP.170 April 1, 2025
Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (PDF) CP.MP.48 August 1, 2024
NICU Apnea Bradycardia Guidelines (PDF) CP.MP.82 May 1, 2024
NICU Discharge Guidelines (PDF) CP.MP.81 May 1, 2024
Nonmyeloablative Allogeneic Stem Cell Transplants (PDF) CP.MP.141 May 1, 2024
Obesity Management & Bariatric Surgery (PDF) QCP.CP.041 May 1, 2024
Obstetrical Home Care Programs (PDF) CP.MP.91 February 1, 2025
Omisirge (omidubicel): Nicotinamide-modified allogeneic hematopoietic progenitor cell therapy (PDF) CP.MP.249 August 1, 2024
Orthognathic Surgery (PDF) CP.MP.202  October 1, 2024
Osteogenic Stimulation (PDF) CP.MP.194 September 1, 2024
Pancreas Transplantation (PDF) CP.MP.102 May 1, 2024
Panniculectomy (PDF) CP.MP.109 October 1, 2024
Pediatric Heart Transplant (PDF) CP.MP.138 October 1, 2024
Pediatric Kidney Transplant (PDF) CP.MP.246 April 1, 2025
Pediatric Liver Transplant (PDF) CP.MP.120 July 1, 2024
Pediatric Oral Function Therapy (PDF) CP.MP.188 July 1, 2024
Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (PDF) CP.MP.147 July 1, 2024
Phototherapy for Neonatal Hyperbilirubinemia (PDF) CP.MP.150 March 1, 2025
Physical, Occupational, and Speech Therapy Services (PDF) CP.MP.49 August 1, 2024
PPO Infertility Treatment (PDF) QCP.CP.031 May 1, 2024
Polymerase Chain Reaction Respiratory Viral Panel Testing (PDF) CP.MP.181 May 1, 2025
Posterior Tibial Nerve Stimulation for Voiding Dysfunction (PDF) CP.MP.133 September 1, 2024
Prosthetics (PDF) QCP.CP.028 May 1, 2024
Proton and Neutron Beam Therapies (PDF) CP.MP.70 May 1, 2025
Reduction Mammoplasty and Gynecomastia Surgery (PDF) CP.MP.51 November 1, 2024
Repair of Nasal Valve Compromise (PDF) CP.MP.210 July 1, 2024
Sacroiliac Joint Fusion (PDF) CP.MP.126 October 1, 2024
Sacroiliac Joint Interventions for Pain Management (PDF) CP.MP.166 September 1, 2024
Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (PDF) CP.MP.146 May 1, 2025
Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy (PDF) CP.MP.174 February 1, 2025
Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (PDF) CP.MP.165 September 1, 2024
Skin and Soft Tissue Substitutes for Chronic Wounds (PDF) CP.MP.185 August 1, 2024
Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (PDF) CP.MP.117 February 1, 2025
Stereotactic Body Radiation Therapy (PDF) CP.MP.22 December 1, 2024
Substance Use Disorders Treatment and Services (PDF) CP.BH.100 May 1, 2024
Tandem Transplant (PDF) CP.MP.162 May 1, 2024
Testing for Select Genitourinary Conditions (PDF) CP.MP.97 May 1, 2025
Therapeutic Utilization of Inhaled Nitric Oxide (PDF) CP.MP.87 February 1, 2025
Thyroid Hormones and Insulin Testing in Pediatrics (PDF) CP.MP.154 November 1, 2024
TMJ Coverage (PDF) QCP.CP.026 May 1, 2024
Total Artificial Heart (PDF) CP.MP.127 August 1, 2024
Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF) CP.MP.163 April 1, 2025
Transplant Service Documentation Requirements (PDF) CP.MP.247 December 1, 2024
Transcranial Magnetic Stimulation for Treatment Resistant Major Depression (PDF) CP.BH.200 August 1, 2024
Trigger Point Injections for Pain Management (PDF) CP.MP.169 September 1, 2024
Urinary Incontinence Devices and Treatments (PDF) CP.MP.142 May 1, 2025
Vagus Nerve Stimulation (PDF) CP.MP.12 February 1, 2025
Ventricular Assist Devices (PDF) CP.MP.46 February 1, 2025
Wireless Motility Capsule (PDF) CP.MP.143 November 1, 2024
Policy Title Policy Number Effective Date
3-Day Payment Window (PDF) CC.PP.500 May 1, 2024
Add-On Code Billed Without Primary Code (PDF) CC.PP.030 May 1, 2024
Ambulatory EEG (PDF) CP.MP.96 May 1, 2024
Assistant Surgeon (PDF) CC.PP.029 May 1, 2024
Autism Spectrum Disorder Treatment QCP.CP.044 May 1, 2024
Bronchial Thermoplasty (PDF) CP.MP.110 November 1, 2023
Clean Claims (PDF) CC.PP.021 May 1, 2024
Coding Overview (PDF) CC.PP.011 May 1, 2024
Cosmetic Procedures (PDF) CC.PP.024 May 1, 2024
E&M Medical Decision-Making (PDF) CC.PP.051 May 1, 2024
Emergency Department Care QCP.PP.040 May 1, 2024
Global Maternity Billing (PDF) CC.PP.016 May 1, 2024
Hospice Services (PDF) CP.MP.54 May 1, 2024
Inpatient Consultation (PDF) CC.PP.038 May 1, 2024
Inpatient Only Procedures (PDF) MP.PP.018 May 1, 2024
Laser Therapy for Skin Conditions (PDF) CP.MP.123 November 1, 2024
Low-frequency Ultrasound and Noncontact Normothermic Wound Therapy (PDF) CP.MP.139 November 1, 2024
Maximum Units (PDF) CC.PP.007 May 1, 2024
Moderate Conscious Sedation (PDF) CC.PP.015 May 1, 2024
Modifier DOS Validation (PDF) CC.PP.034 May 1, 2024
Modifier to Procedure Code Validation (PDF) CC.PP.028 May 1, 2024
Multiple CPT Code Replacement (PDF) CC.PP.033 May 1, 2024
NCCI Unbundling (PDF) CC.PP.031 May 1, 2024
Never Paid Events (PDF) CC.PP.017 May 1, 2024
Non Face-to-Face Services (PDF) QCP.PP.017 May 1, 2024
Outpatient Consultation (PDF) CC.PP.039 May 1, 2024
Pediatric Dental (PDF) QCP.PP.036 May 1, 2024
Physician Extenders (PDF) QCP.PP.032 May 1, 2024
Place of Service Mismatch (PDF) CC.PP.063  May 1, 2024
Platelet Rich Plasma (PDF) QCP.PP.010 May 1, 2024
Post-Operative Visits (PDF) CC.PP.042 May 1, 2024
Pre-Operative Visits (PDF) CC.PP.041 May 1, 2024
Preventive Health Benefit (PDF) QCP.PP.016 May 1, 2024
Problem Oriented Visits with Preventative Services (PDF) CC.PP.057 May 1, 2024
Prolonged Medical Services (PDF) QCP.PP.013 May 1, 2024
Pulmonary Function Testing (PDF) CP.MP.242 November 1, 2024
Pulse Oximetry (PDF) CC.PP.025 May 1, 2024
Robotic Surgery (PDF) CC.PP.050 May 1, 2024
Routine & Complex Office Procedures (PDF) QCP.PP.025 May 1, 2024
Same Day Visits (PDF) CC.PP.040 May 1, 2024
Severe Malnutrition (PDF) CC.PP.145 November 1, 2024
Skilled Nursing Facility Leveling (PDF) CC.PP.206 May 1, 2025
Status "B" Bundled Services (PDF) CC.PP.046 May 1, 2024
Status P Bundled Services (PDF) CC.PP.049 May 1, 2024
Supplies Billed on Same Day As Surgery (PDF) CC.PP.032 May 1, 2024
Transgender Related Services (PDF) CC.PP.047 May 1, 2024
Ultrasound in Pregnancy (PDF) CP.MP.38 November 1, 2024
Unbundled Professional Services (PDF) CC.PP.043 May 1, 2024
Unlisted Procedure Codes (PDF) CC.PP.009 May 1, 2024
Urine Specimen Validity Testing (PDF) CC.PP.056 May 1, 2024
Urodynamic Testing (PDF) CP.MP.98 November 1, 2024
 
Policy Title Policy Number Effective Date
Abaloparatide (Tymlos) (PDF)  CP.PHAR.345  April 1, 2025
Abatacept (Orencia) (PDF) CP.PHAR.241 January 1, 2025
Abemaciclib (Verzenio) (PDF) CP.PHAR.355 January 1, 2025
Abiraterone (Zytiga) (PDF)  CP.PHAR.84  April 1, 2025
AbobotulinumtoxinA (Dysport) (PDF) CP.PHAR.230 Retire by July 1, 2025
AbobotulinumtoxinA (Dysport) (PDF)  CP.PHAR.230  July 1, 2025
Abrocitinib (Cibinqo) (PDF) CP.PHAR.578 January 1, 2025
Acalabrutinib (Calquence) (PDF) CP.PHAR.366 Retire by June 1, 2025
Acalabrutinib (Calquence) (PDF)  CP.PHAR.366 June 1, 2025
Acoramidis (Attruby) (PDF) CP.PHAR.683 April 1, 2025
Acyclovir Buccal tab (Sitavig) (PDF) CP.PMN.210 January 1, 2025
Adagrasib (Krazati) (PDF) CP.PHAR.605 Retire by June 1, 2025
Adagrasib (Krazati) (PDF)  CP.PHAR.605  June 1, 2025
ADAMTS13, recombinant-krhn (Adzynma) (PDF)  CP.PHAR.635  April 1, 2025
Adefovir (Hepsera) (PDF) CP.PHAR.142 January 1, 2025
Ado-Trastuzumab Emtansine (Kadcyla) (PDF) CP.PHAR.229 Retire by July 1, 2025
Ado-Trastuzumab Emtansine (Kadcyla) (PDF)  CP.PHAR.229  July 1, 2025
Aducanumab-avwa (Aduhelm) (PDF) CP.PHAR.468 Retire by July 1, 2025
Aducanumab-avwa (Aduhelm) (PDF)  CP.PHAR.468  July 1, 2025
Afamelanotide (Scenesse) (PDF)  CP.PHAR.444  April 1, 2025
Afamitresgene Autoleucel (Tecelra) (PDF)  CP.PHAR.678  May 1, 2025
Afatinib (Gilotrif) (PDF) CP.PHAR.298 Retire by July 1, 2025
Afatinib (Gilotrif) (PDF)  CP.PHAR.298  July 1, 2025
Aflibercept (Eylea, Eylea HD) (PDF)   CP.PHAR.184   May 1, 2025
Agalsidase Beta (Fabrazyme) (PDF) CP.PHAR.158 Retire by September 1, 2025
Agalsidase Beta (Fabrazyme) (PDF)  CP.PHAR.158  September 1, 2025
Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF) CP.PMN.138 Retire by July 1, 2025
Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF)  CP.PMN.138  July 1, 2025
Alectinib (Alecensa) (PDF) CP.PHAR.369 Retire by July 1, 2025
Alectinib (Alecensa) (PDF)  CP.PHAR.369  July 1, 2025
Alemtuzumab (Lemtrada) (PDF) CP.PHAR.243 Retire by July 1, 2025
Alemtuzumab (Lemtrada) (PDF)  CP.PHAR.243  July 1, 2025
Alendronate (Binosto, Fosamax plus D) (PDF)  CP.PMN.88  April 1, 2025
Alglucosidase Alfa (Lumizyme) (PDF)  CP.PHAR.160  April 1, 2025
Allogeneic Cultured Keratinocytes and Dermal Fibroblasts in Murine Collagen-dsat (StrataGraft) (PDF)   CP.PHAR.562  April 1, 2025
Allogenic Processed Thymus Tissue-agdc (Rethymic) (PDF)  CP.PHAR.563  April 1, 2025
Alpelisib (Piqray) (PDF) CP.PHAR.430 January 1, 2025
Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF)   CP.PHAR.94  April 1, 2025
Amantadine ER (Gocovri,Osmolex ER) (PDF)  CP.PMN.89  April 1, 2025
Ambrisentan (Letairis®) (PDF)  CP.PHAR.190  April 1, 2025
Amifampridine (Firdapse)(PDF)  CP.PHAR.411  April 1, 2025
Amikacin (Arikayce)(PDF) CP.PHAR.401 January 1, 2025
Amisulpride (Barhemsys) (PDF)  CP.PMN.236 October 1, 2024
Amivantamab-vmjw (Rybrevant) (PDF) CP.PHAR.544 January 1, 2025
Anifrolumab-fnia (Saphnelo) (PDF) CP.PHAR.551 March 1, 2025
Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF)  CP.PHAR.217  April 1, 2025
Antithrombin III (ATryn, Thrombate III) (PDF)  CP.PHAR.564  April 1, 2025
Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF) CP.PHAR.506 January 1, 2025
Apalutamide (Erleada) (PDF) CP.PCH.45 Retire by July 1, 2025
Apalutamide (Erleada) (PDF)  CP.PCH.45  July 1, 2025
Apomorphine (Apokyn) (PDF) CP.PHAR.488 Retire by July 1, 2025
Apomorphine (Apokyn) (PDF)  CP.PHAR.488  July 1, 2025
Aprepitant (Emend®) (PDF) CP.PMN.19 January 1, 2025
Aprocitentan (Tryvio) (PDF) CP.PHAR.676 Retire by July 1, 2025
Aprocitentan (Tryvio) (PDF)  CP.PHAR.676  July 1, 2025
Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) (PDF) CP.PHAR.290 May 1, 2024
Aripiprazole Orally Disintegrating Tablet, Oral Film (Opipza) (PDF)  CP.PMN.300 April 1, 2025
Armodafinil (Nuvigil) (PDF) CP.PMN.35 Retire by July 1, 2025
Armodafinil (Nuvigil) (PDF)  CP.PMN.35  July 1, 2025
Asciminib (Scemblix) (PDF) CP.PHAR.565 Retire by June 1, 2025
Asciminib (Scemblix) (PDF)  CP.PHAR.565  June 1, 2025
Asenapine (Saphris, Secuado) (PDF) CP.PMN.15 January 1, 2025
Asfotase Alfa (Strensiq) (PDF) CP.PHAR.328 January 1, 2025
Aspirin-dipyridamole (Aggrenox) (PDF)  CP.PMN.20  April 1, 2025
Atezolizumab (Tecentriq) (PDF) CP.PHAR.235 Retire by June 1, 2025
AtezolizumaAtrasentan (Vanrafia)b (Tecentriq) (PDF)  CP.PHAR.235  June 1, 2025
Atidarsagene autotemcel (Lenmeldy) (PDF)  CP.PHAR.602  April 1, 2025
Atogepant (Qulipta) (PDF) CP.PHAR.566 January 1, 2025
Atrasentan (Vanrafia) (PDF) CP.PHAR.727 July 1, 2025
Avacincaptad pegol (Izervay) (PDF)  CP.PHAR.641  May 1, 2025
Avacopan (Tavneos) (PDF)  CP.PHAR.515  April 1, 2025
Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF)  CP.PHAR.521  April 1, 2025
Avapritinib (Ayvakit) (PDF)  CP.PHAR.454  April 1, 2025
Avatrombopag (Doptelet) (PDF) CP.PHAR.130 January 1, 2025
Avelumab (Bavencio) (PDF)  CP.PHAR.333  April 1, 2025
Axatilimab-csfr (Niktimvo) (PDF)  CP.PHAR.691  April 1, 2025
Axicabtagene Ciloleucel (Yescarta) (PDF) CP.PHAR.362 Retire by June 1, 2025
Axicabtagene Ciloleucel (Yescarta) (PDF)  CP.PHAR.362  June 1, 2025
Axitinib (Inlyta) (PDF)  CP.PHAR.100 April 1, 2025
Azacitidine (Onureg, Vidaza) (PDF) CP.PHAR.387 March 1, 2025
Azelaic Acid (Finacea) (PDF) HIM.PA.119 January 1, 2025
Aztreonam (Cayston) (PDF) CP.PHAR.209 January 1, 2025
Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF) CP.PHAR.149 January 1, 2025
Baloxavir Marboxil (Xofluza) (PDF) CP.PMN.185 January 1, 2025
Bedaquiline (Sirturo) (PDF)  CP.PMN.212  April 1, 2025
Belantamab Mafodotin-blmf (Blenrep) (PDF) CP.PHAR.469 Retire by July 1, 2025
Belantamab Mafodotin-blmf (Blenrep) (PDF)  CP.PHAR.469  July 1, 2025
Belatacept (Nulojix) (PDF) CP.PHAR.201 January 1, 2025
Belimumab (Benlysta) (PDF) CP.PHAR.88 Retire by July 1, 2025
Belimumab (Benlysta) (PDF)  CP.PHAR.88  July 1, 2025
Belinostat (Beleodaq) (PDF) CP.PHAR.311 March 1, 2025
Belumosudil (Rezurock) (PDF) CP.PHAR.552 January 1, 2025
Belzutifan (Welireg) (PDF) CP.PHAR.553 January 1, 2025
Bempedoic acid (Nexletol), bempedoic acid-ezetimibe (Nexlizet) (PDF)  CP.PMN.237  April 1, 2025
Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (PDF) CP.PHAR.307 March 1, 2025
Benralizumab (Fasenra) (PDF) HIM.PA.SP70 March 1, 2025
Benznidazole (PDF)  CP.PMN.90  April 1, 2025
Berdazimer (Zelsuvmi) (PDF) CP.PMN.293 Retire by July 1, 2025
Berdazimer (Zelsuvmi) (PDF)  CP.PMN.293  July 1, 2025
Beremagene geperpavec-svdt (Vyjuvek) (PDF) CP.PHAR.592 September 1, 2024
Berotralstat (Orladeyo) (PDF) HIM.PA.169 January 1, 2025
Betaine (Cystadane) (PDF) CP.PHAR.143 January 1, 2025
Betamethasone Dipropionate Spray (Sernivo) (PDF) CP.PMN.182 January 1, 2025
Betibeglogene Autotemcel (Zynteglo) (PDF)  CP.PHAR.545 October 1, 2024
Bevacizumab (Alymsys, Avastin, Mvasi, Vegzelma, Zirabev) (PDF) CP.PHAR.93 March 1, 2025
Bexarotene (Targretin Capsules, Gel) (PDF) CP.PHAR.75 Retire by July 1, 2025
Bexarotene (Targretin Capsules, Gel) (PDF)  CP.PHAR.75  July 1, 2025
Bezlotoxumab (Zinplava) (PDF)  CP.PHAR.300  April 1, 2025
Bimatoprost Implant (Durysta) (PDF) CP.PHAR.486 Retire by July 1, 2025
Bimatoprost Implant (Durysta) (PDF)  CP.PHAR.486  July 1, 2025
Binimetinib (Mektovi) (PDF) CP.PHAR.50 Retire by July 1, 2025
Binimetinib (Mektovi) (PDF)  CP.PHAR.50  July 1, 2025
Biologic and Non-biologic DMARDs (PDF)  HIM.PA.SP60  Retire by September 1, 2025
Biologic and Non-biologic DMARDs (PDF)   HIM.PA.SP60 September 1, 2025
Birch Triterpenes (Filsuvez) (PDF) CP.PHAR.669 Retire by June 1, 2025
Birch Triterpenes (Filsuvez) (PDF)  CP.PHAR.669  June 1, 2025
Blinatumomab (Blincyto) (PDF)  CP.PHAR.312 November 1, 2024
Bortezomib (Velcade) (PDF)  CP.PHAR.410  April 1, 2025
Bosentan (Tracleer®) (PDF)  CP.PHAR.191  April 1, 2025
Bosutinib (Bosulif) (PDF) CP.PHAR.105 Retire by July 1, 2025
Bosutinib (Bosulif) (PDF)  CP.PHAR.105  July 1, 2025
Brand Name Override and Non-Formulary Medications (PDF) HIM.PA.103 Retire by August 1, 2025
Brand Name Override and Non-Formulary Medications (PDF)  HIM.PA.103  August 1, 2025
Brentuximab Vedotin (Adcetris) (PDF)  CP.PHAR.303 Retire by July 1, 2025
Brentuximab Vedotin (Adcetris) (PDF)   CP.PHAR.303  July 1, 2025
Brexanolone (Zulresso) (PDF) CP.PHAR.417 Retire by July 1, 2025
Brexanolone (Zulresso) (PDF)  CP.PHAR.417  July 1, 2025
Brexpiprazole (Rexulti) (PDF) CP.PMN.68 January 1, 2025
Brexucabtagene Autoleucel (Tecartus) (PDF)  CP.PHAR.472  April 1, 2025
Brigatinib (Alunbrig) (PDF) CP.PHAR.342 Retire by July 1, 2025
Brigatinib (Alunbrig) (PDF)  CP.PHAR.342  July 1, 2025
Brimonidine Tartrate (Mirvaso) (PDF) CP.PMN.192 Retire by July 1, 2025
Brimonidine Tartrate (Mirvaso) (PDF)  CP.PMN.192  July 1, 2025
Brinzolamide/Brimonidine (Simbrinza) (PDF) HIM.PA.15 January 1, 2025
Brivaracetam (Briviact) (PDF) CP.PMN.297 January 1, 2025
Brolucizumab-dbll (Beovu) (PDF) CP.PHAR.445 Retire by June 1, 2025
Brolucizumab-dbll (Beovu) (PDF)  CP.PHAR.445  June 1, 2025
Budesonide (Eohilia, Uceris) (PDF) CP.PMN.294 Retire by July 1, 2025
Budesonide (Eohilia, Uceris) (PDF)  CP.PMN.294  July 1, 2025
Budesonide (Tarpeyo) (PDF)  CP.PHAR.572  April 1, 2025
Bupropion/Naltrexone (Contrave) (PDF) CP.PCH.12 Retire by July 1, 2025
Bupropion/Naltrexone (Contrave) (PDF)  CP.PCH.12  July 1, 2025
Burosumab-twza (Crysvita) (PDF) CP.PHAR.11 May 1, 2024
Butorphanol Nasal Spray (PDF) HIM.PA.46 Retire by July 1, 2025
Butorphanol Nasal Spray (PDF)  HIM.PA.46  July 1, 2025
C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF) HIM.PA.170 September 1, 2024
Cabazitaxel (Jevtana) (PDF) CP.PHAR.316 Retire by July 1, 2025
Cabazitaxel (Jevtana) (PDF)  CP.PHAR.316  July 1, 2025
Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (PDF)   CP.PHAR.573  April 1, 2025
Cabozantinib (Cometriq®, Cabometyx®) (PDF)  CP.PHAR.111 April 1, 2025
Calcifediol (Rayaldee) (PDF) CP.PMN.76 January 1, 2025
Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF) CP.PMN.181 January 1, 2025
Canakinumab (Ilaris) (PDF) CP.PHAR.246 Retire by September 1, 2025
Canakinumab (Ilaris) (PDF)  CP.PHAR.246  September 1, 2025
Cannabidiol (Epidiolex) (PDF) CP.PMN.164 January 1, 2025
Capecitabine (Xeloda) (PDF) CP.PHAR.60 Retire by July 1, 2025
Capecitabine (Xeloda) (PDF)  CP.PHAR.60  July 1, 2025
Capivasertib (Truqap) (PDF)  CP.PHAR.663  April 1, 2025
Caplacizumab-yhdp (Cablivi) (PDF) CP.PHAR.416 Retire by July 1, 2025
Caplacizumab-yhdp (Cablivi) (PDF)  CP.PHAR.416  July 1, 2025
Capmatinib (Tabrecta) (PDF) CP.PHAR.494 January 1, 2025
CarbidopaLevodopa (Crexont, Rytary,Duopa, Dhivy), FoscarbidopaLevodopa (Vyalev) (PDF) CP.PMN.238 January 1, 2025
Carfilzomib (Kyprolis) (PDF) CP.PHAR.309 March 1, 2025
Carglumic acid (Carbaglu®) (PDF) CP.PHAR.206 Retire by June 1, 2025
Carglumic acid (Carbaglu®) (PDF)  CP.PHAR.206  June 1, 2025
Cariprazine (Vraylar) (PDF) CP.PMN.91 January 1, 2025
Casimersen (Amondys 45) (PDF)  CP.PHAR.470  April 1, 2025
Cemiplimab-rwlc (Libtayo) (PDF) CP.PHAR.397 January1, 2025
Cenegermin-bkbj (Oxervate)(PDF)  CP.PMN.186  April 1, 2025
Cenobamate (Xcopri) (PDF)  CP.PMN.231  April 1, 2025
Ceritinib (Zykadia) (PDF) CP.PHAR.349 Retire by September 1, 2025
Ceritinib (Zykadia) (PDF)  CP.PHAR.349  September 1, 2025
Cerliponase alfa (Brineura) (PDF) CP.PHAR.338 October 1, 2024
Cetuximab (Erbitux) (PDF) CP.PHAR.317 March 1, 2025
Chenodiol (Chenodal) (PDF)  CP.PMN.239  May 1, 2025
Chlorambucil (Leukeran) (PDF) CP.PHAR.554 January 1, 2025
Chloramphenicol Sodium Succinate (PDF) CP.PHAR.388 September 1, 2024
Cholic Acid (Cholbam) (PDF) CP.PHAR.390 January 1, 2025
Ciclopirox (Penlac) (PDF)  CP.PMN.24  April 1, 2025
Ciltacabtagene Autoleucel (Carvykti) (PDF) CP.PHAR.533 Retire by July 1, 2025
Ciltacabtagene Autoleucel (Carvykti) (PDF)  CP.PHAR.533  July 1, 2025
Cinacalcet (Sensipar) (PDF) CP.PHAR.61 January 1, 2025
Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF)  CP.PHAR.567  April 1, 2025
Ciprofloxacin/Fluocinolone (Otovel) (PDF) CP.PMN.249 January 1, 2025
Ciprofloxacin-Dexamethasone (Ciprodex) (PDF) CP.PMN.248 January 1, 2025
Cladribine (Mavenclad) (PDF) CP.PHAR.422 Retire by July 1, 2025
Cladribine (Mavenclad) (PDF)  CP.PHAR.422  July 1, 2025
Clascoterone (Winlevi) (PDF)  CP.PMN.257  April 1, 2025
Clobazam (Onfi) (PDF) CP.PMN.54 January 1, 2025
CNS Stimulants (PDF) CP.PMN.92 Retire by June 1, 2025
CNS Stimulants (PDF)  CP.PMN.92 June 1, 2025
Cobimetinib (Cotellic) (PDF) CP.PHAR.380 Retire by July 1, 2025
Cobimetinib (Cotellic) (PDF)  CP.PHAR.380  July 1, 2025
Colchicine (Colcrys, Lodoco) (PDF)  CP.PMN.123  April 1, 2025
Colesevelam (Welchol) (PDF) CP.PMN.250 January 1, 2025
Collagenase Clostridium Histolyticum (Xiaflex) (PDF) CP.PHAR.82 September 1, 2024
Colonoscopy Preparation Products (PDF) CP.PCH.43 January 1, 2025
Compounded Medications (PDF)   CP.PMN.280   May 1, 2025
Concizumab (Alhemo) (PDF) CP.PHAR.625 Retire by September 1, 2025
Concizumab (Alhemo) (PDF)  CP.PHAR.625  September 1, 2025
Conjugated Estrogens/Bazedoxifene (Duavee) (PDF)  CP.PMN.258  April 1, 2025
Continuous Glucose Monitors (PDF) AR.QC.PMN.214 January 1, 2025 
Copanlisib (Aliqopa) (PDF) CP.PHAR.357 March 1, 2025
Corticosteroids for Ophthalmic Injection (Dextenza, Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (PDF) CP.PHAR.385 June 1, 2025
Cosibelimab-Ipdl (Unloxcyt) (PDF) CP.PHAR.711 April 1, 2025
Cosyntropin (Cortrosyn) (PDF) CP.PHAR.203 Retire by June 1, 2025
Cosyntropin (Cortrosyn) (PDF)  CP.PHAR.203  June 1, 2025
Crinecerfont (Crenessity) (PDF) CP.PHAR.692 April 1, 2025
Crisaborole (Eucrisa) (PDF) CP.PMN.110 Retire by July 1, 2025
Crisaborole (Eucrisa) (PDF)  CP.PMN.110  July 1, 2025
Crizanlizumab-tmca (Adakveo) (PDF)  CP.PHAR.449  April 1, 2025
Crizotinib (Xalkori) (PDF) CP.PHAR.90 Retire by July 1, 2025
Crizotinib (Xalkori) (PDF)  CP.PHAR.90  July 1, 2025
Crovalimab (PiaSky) (PDF)  CP.PHAR.664  April 1, 2025
Cyclosporine ophthalmic emulsion (Cequa, Klarity-C, Restasis, Verkazia, Vevye) (PDF) CP.PMN.48 Retire by July 1, 2025
Cyclosporine ophthalmic emulsion (Cequa, Klarity-C, Restasis, Verkazia, Vevye) (PDF)  CP.PMN.48  July 1, 2025
Cysteamine Ophthalmic (Cystaran, Cystadrops) (PDF) CP.PMN.130 Retire by July 1, 2025
Cysteamine Ophthalmic (Cystaran, Cystadrops) (PDF)  CP.PMN.130  July 1, 2025
Cysteamine oral (Cystagon, Procysbi) (PDF) CP.PHAR.155 Retire by September 1, 2025
Cysteamine oral (Cystagon, Procysbi) (PDF)  CP.PHAR.155  September 1, 2025
Cytomegalovirus Immune Globulin (Cytogam) (PDF) CP.PHAR.277 September 1, 2024
Dabrafenib (Tafinlar) (PDF) CP.PHAR.239 Retire by July 1, 2025
Dabrafenib (Tafinlar) (PDF)  CP.PHAR.239  July 1, 2025
Dacomitinib (Vizimpro) (PDF) CP.PHAR.399 January 1, 2025
Dalfampridine (Ampyra) (PDF) CP.PHAR.248 Retire by July 1, 2025
Dalfampridine (Ampyra) (PDF)  CP.PHAR.248  July 1, 2025
Dalteparin (Fragmin) (PDF)  CP.PHAR.225  April 1, 2025
Danicopan (ALXN2040) (PDF) CP.PHAR.665 January 1, 2025
Daprodustat (Jesduvroq) (PDF) CP.PHAR.628 Retire by July 1, 2025
Daprodustat (Jesduvroq) (PDF)  CP.PHAR.628  July 1, 2025
Dapsone (Aczone Gel) (PDF) CP.PCH.32 January 1, 2025
Daptomycin (Cubicin, Cubicin RF, Dapzura RT) (PDF) CP.PHAR.351 September 1, 2024
Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (PDF) CP.PHAR.310 November 1, 2024
Darbepoetin alfa (Aranesp) (PDF) CP.PHAR.236 Retire by September 1, 2025
Darbepoetin alfa (Aranesp) (PDF)  CP.PHAR.236  September 1, 2025
Darolutamide (Nubeqa) (PDF) CP.PHAR.435 January 1, 2025
Dasabuvir-Ombitasvir-Paritaprevir-Ritonavir (Viekira Pak) (PDF) HIM.PA.SP61 January 1, 2025
Dasatinib (Sprycel) (PDF) CP.PHAR.72 Retire by July 1, 2025
Dasatinib (Sprycel) (PDF)  CP.PHAR.72  July 1, 2025
Datopotamab Deruxtecan-dlnk (Datroway) (PDF) CP.PHAR.715 July 1, 2025
Daunorubicin/Cytarabine (Vyxeos) (PDF) CP.PHAR.352 January1, 2025
DaxibotulinumtoxinA-lanm (Daxxify) (PDF) CP.PHAR.651 January 1, 2025
Decitabine-Cedazuridine (Inqovi) (PDF) CP.PHAR.479 Retire by July 1, 2025
Decitabine-Cedazuridine (Inqovi) (PDF)  CP.PHAR.479  July 1, 2025
Deferasirox (Exjade Jadenu) (PDF) CP.PHAR.145 January 1, 2025
Deferiprone (Ferriprox) (PDF) CP.PHAR.147 January 1, 2025
Deferoxamine (Desferal) (PDF) CP.PHAR.146 September 1, 2024
Deflazacort (Emflaza) (PDF)  CP.PHAR.331  April 1, 2025
Degarelix Acetate (Firmagon) (PDF) CP.PHAR.170 January 1, 2025
Delafloxacin (Baxdela) (PDF) CP.PMN.115 September 1, 2024
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF) CP.PHAR.593 Retire by June 1, 2025
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF)  CP.PHAR.593  June 1, 2025
Denileukin Diftitox-cxdl (Lymphir) (PDF)  CP.PHAR.693  May 1, 2025
Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (PDF) CP.PHAR.58 Retire by June 1, 2025
Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (PDF)   CP.PHAR.58  June 1, 2025
Desmopressin Acetate (DDAVP, Stimate, Noctiva) (PDF) CP.PHAR.214 Retire by June 1, 2025
Desmopressin Acetate (DDAVP, Stimate, Noctiva) (PDF)  CP.PHAR.214  June 1, 2025
Deutetrabenazine (Austedo, Austedo XR) (PDF) CP.PCH.42 Retire by July 1, 2025
Deutetrabenazine (Austedo, Austedo XR) (PDF)  CP.PCH.42  July 1, 2025
Dexrazoxane (Totect) (PDF) CP.PHAR.418 Retire by September 1, 2025
Dexrazoxane (Totect) (PDF)  CP.PHAR.418  September 1, 2025
Dextromethorphan-bupropion (Auvelity) (PDF) CP.PMN.284 January 1, 2025
Dextromethorphan-Quinidine (Nuedexta) (PDF) CP.PMN.93 April 1, 2025
Diazepam (Libervant, Valtoco) (PDF) CP.PMN.216 January 1, 2025
Diazoxide Choline (Vykat XR) (PDF) CP.PHAR.701 July 1, 2025
Dichlorphenamide (Keveyis) (PDF)  CP.PMN.261  April 1, 2025
Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF) CP.PCH.28 January 1, 2025
Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (PDF) CP.PHAR.249 Retire by July 1, 2025
Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (PDF)  CP.PHAR.249  July 1, 2025
Dipeptidyl Peptidase-4 Inhibitors (PDF)   HIM.PA.58   May 1, 2025
Dolasetron (Anzemet) (PDF) CP.PMN.141 January 1, 2025
Donanemab-azbt (Kisunla) (PDF) CP.PHAR.594 March 1, 2025
Dornase alfa (Pulmozyme) (PDF) CP.PHAR.212 January 1, 2025
Dostarlimab-gxly (Jemperli) (PDF) CP.PHAR.540 November 1, 2024
Doxepin (Silenor, Prudoxin, Zonalon) HIM.PA.147 January 1, 2025
Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) (PDF) CP.PMN.79 Retire by July 1, 2025
Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) (PDF)  CP.PMN.79  July 1, 2025
Dupilumab (Dupixent) (PDF) HIM.PA.SP69 Retire by June 1, 2025
Dupilumab (Dupixent) (PDF)  HIM.PA.SP69 June 1, 2025
Durvalumab (Imfinzi) (PDF)  CP.PHAR.339  September 1, 2025
Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF) CP.PMN.128 Retire by July 1, 2025
Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF)  CP.PMN.128  July 1, 2025
Duvelisib (Copiktra) (PDF) CP.PHAR.400 January 1, 2025
Ecallantide (Kalbitor) (PDF) CP.PHAR.177 September 1, 2024
Eculizumab (Soliris) (PDF)  CP.PHAR.97  May 1, 2025
Edaravone (Radicava, Radicava ORS) (PDF) CP.PHAR.343 Retire by September 1, 2025
Edaravone (Radicava, Radicava ORS) (PDF)  CP.PHAR.343  September 1, 2025
Efgartigimod Alfa-fcab, Efgartigimod/-Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (PDF) CP.PHAR.555 Retire by June 1, 2025
Efgartigimod Alfa-fcab, Efgartigimod/-Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (PDF)   CP.PHAR.555  June 1, 2025
Efinaconazole (Jublia) (PDF)  CP.PMN.25  April 1, 2025
Eflornithine (Iwilfin) (PDF)  CP.PHAR.670  April 1, 2025
Elacestrant (Orserdu) (PDF) CP.PHAR.623 Retire by September 1, 2025
Elacestrant (Orserdu) (PDF)  CP.PHAR.623  September 1, 2025
Eladocagene Exuparvovec-tneq (Kebilidi) (PDF)  CP.PHAR.595  May 1, 2025
Elafibranor (Iqirvo) (PDF) CP.PHAR.688 January 1, 2025
Elagolix (Orilissa), elagolix-estradiol-norethindrone (Oriahnn) (PDF) CP.PHAR.136 January 1, 2025
Elapegademase-lvlr (Revcovi) (PDF) CP.PHAR.419 Retire by July 1, 2025
Elapegademase-lvlr (Revcovi) (PDF)   CP.PHAR.419  July 1, 2025
Elbasvir/Grazoprevir (Zepatier) (PDF) HIM.PA.SP62 January 1, 2025
Elexacaftor-ivacaftor-tezacaftor (Trikafta) (PDF)  CP.PHAR.440  April 1, 2025
Eliglustat (Cerdelga) (PDF) CP.PHAR.153 Retire by July 1, 2025
Eliglustat (Cerdelga) (PDF)  CP.PHAR.153  July 1, 2025
Elivaldogene Autotemcel (Skysona) (PDF) CP.PHAR.556 January 1, 2025
Elosulfase Alfa (Vimizim) (PDF) CP.PHAR.162 Retire by July 1, 2025
Elosulfase Alfa (Vimizim) (PDF)  CP.PHAR.162  July 1, 2025
Elotuzumab (Empliciti) (PDF) CP.PHAR.308 March 1, 2025
Elranatamab-bcmm (Elrexfio) (PDF) CP.PHAR.652 January 1, 2025
Eltrombopag (Promacta®) (PDF)  CP.PHAR.180  April 1, 2025
Eluxadoline (Viberzi) (PDF) CP.PMN.170 January 1, 2025
Emapalumab-lzsg (Gamifant) (PDF)  CP.PHAR.402  April 1, 2025
Emicizumab-kxwh (Hemlibra) (PDF)  CP.PHAR.370  April 1, 2025
Emtricitabine-tenofovir alafenamide (Descovy) (PDF)  CP.PMN.235  July 1, 2025
Ensartinib (Ensacove) (PDF) CP.PHAR.712 April 1, 2025
Enasidenib (Idhifa) (PDF) CP.PHAR.363 January 1, 2025
Encorafenib (Braftovi) (PDF)  CP.PHAR.127  July 1, 2025
Enfortumab Vedotin-ejfv (Padcev) (PDF)  CP.PHAR.455  April 1, 2025
Enfuvirtide (Fuzeon) (PDF) CP.PHAR.41 August 1, 2024
Enoxaparin (Lovenox) (PDF)  CP.PHAR.224  April 1, 2025
Entecavir (Baraclude) (PDF) HIM.PA.08 Retire by July 1, 2025
Entecavir (Baraclude) (PDF)  HIM.PA.08  July 1, 2025
Entrectinib (Rozlytrek) (PDF) CP.PHAR.441 January 1, 2025
Enzalutamide (Xtandi) (PDF)  CP.PHAR.106 April 1, 2025
Epcoritamab-bysp (Epkinly) (PDF) CP.PHAR.634 September 1, 2024
Epinephrine (Epipen, Epipen Jr, Neffy, Auvi-Q) (PDF) CP.PCH.55 July 1, 2025
Eplontersen (Wainua) CP.PHAR.633 Retire by July 1, 2025
Eplontersen (Wainua)  CP.PHAR.633  July 1, 2025
Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF) CP.PHAR.237 Retire by July 1, 2025
Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF)   CP.PHAR.237  July 1, 2025
Epoprostenol (Flolan, Veletri) (PDF)  CP.PHAR.192  April 1, 2025
Eptinezumab-jjmr (Vyepti) (PDF) HIM.PA.SP64 March 1, 2025
Erdafitinib (Balversa) (PDF) CP.PHAR.423 January 1, 2025
Erenumab-aaoe (Aimovig) (PDF) HIM.PA.SP65 January 1, 2025
Eribulin Mesylate (Halaven) (PDF) CP.PHAR.318 January 1, 2025
Erlotinib (Tarceva) (PDF) CP.PHAR.74 Retire by July 1, 2025
Erlotinib (Tarceva) (PDF)  CP.PHAR.74  July 1, 2025
Erwinia Asparaginase (Erwinaze, Rylaze) (PDF)  CP.PHAR.301  April 1, 2025
Esketamine (Spravato) (PDF)  CP.PMN.199  Retire by July 1, 2025
Esketamine (Spravato) (PDF)   CP.PMN.199   July 1, 2025
Estradiol Vaginal Ring (Femring) (PDF) CP.PMN.263 January 1, 2025
Etelcalcetide (Parsabiv) (PDF) CP.PHAR.379 September 1, 2024
Eteplirsen (Exondys 51) (PDF)  CP.PHAR.288  April 1, 2025
Etranacogene Dezaparvovec-drlb (Hemgenix) (PDF)  CP.PHAR.580  April 1, 2025
Everolimus (Afinitor, Afinitor Disperz, Zortress)(PDF)  CP.PHAR.63  April 1, 2025
Evinacumab-dgnb (Evkeeza) (PDF)  HIM.PA.166  April 1, 2025
Evolocumab (Repatha) (PDF)  HIM.PA.156  June 1, 2025
Exagamglogene autotemcel (Casgevy) (PDF) CP.PHAR.603 Retire by June 1, 2025
Exagamglogene autotemcel (Casgevy) (PDF)  CP.PHAR.603  June 1, 2025
Factor IX (Human, Recombinant) (PDF)  CP.PHAR.218  April 1, 2025
Factor IX Complex, Human (Profilnine) (PDF)  CP.PHAR.219  April 1, 2025
Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF) CP.PHAR.220 Retire by June 1, 2025
Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF)   CP.PHAR.220  June 1, 2025
Factor VIII (Human, Recombinant) (PDF)   CP.PHAR.215   May 1, 2025
Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF) CP.PHAR.216 Retire by June 1, 2025
Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF)   CP.PHAR.216  June 1, 2025
Factor XIII A-Subunit, Recombinant (Tretten) (PDF)  CP.PHAR.222  April 1, 2025
Factor XIII, Human (Corifact) (PDF)  CP.PHAR.221  April 1, 2025
Famotidine-Ibuprofen (Duexis) (PDF) CP.PMN.120 Retire by July 1, 2025
Famotidine-Ibuprofen (Duexis) (PDF)  CP.PMN.120  July 1, 2025
Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (PDF)  CP.PHAR.456  April 1, 2025
Faricimab-svoa (Vabysmo) (PDF)  CP.PHAR.581  April 1, 2025
Febuxostat (Uloric) (PDF)  CP.PMN.57  April 1, 2025
Fecal microbiota spores, live-brpk (Vowst) (PDF) CP.PHAR.632 January 1, 2025
Fecal microbiota, live-jslm (Rebyota) (PDF)  CP.PHAR.613  April 1, 2025
Fedratinib (Inrebic) (PDF) CP.PHAR.442 January 1, 2025
Fenfluramine (Fintepla) (PDF) CP.PMN.246 January 1, 2025
Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF) CP.PMN.127 Retire by July 1, 2025
Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF)  CP.PMN.127  July 1, 2025
Ferric Carboxymaltose (Injectafer) (PDF)  CP.PHAR.234  April 1, 2025
Ferric Derisomaltose (Monoferric) (PDF)  CP.PHAR.480 Retire by July 1, 2025
Ferric Derisomaltose (Monoferric) (PDF)   CP.PHAR.480  July 1, 2025
Ferric Maltol (Accrufer) (PDF) CP.PMN.213 January 1, 2025
Ferric Pyrophosphate (Triferic, Triferic Avnu ) (PDF) CP.PHAR.624 Retire by July 1, 2025
Ferric Pyrophosphate (Triferic, Triferic Avnu ) (PDF)  CP.PHAR.624  July 1, 2025
Ferumoxytol (Feraheme) (PDF)  CP.PHAR.165  April 1, 2025
Fezolinetant (Veozah) (PDF) CP.PMN.289 March 1, 2025
Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (PDF) CP.PHAR.526 Retire by July 1, 2025
Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (PDF)  CP.PHAR.526  July 1, 2025
Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF) CP.PHAR.643 January1, 2025
Filgrastim (Neupogen, Zarxio, Granix, Nivestym, Releuko, Nypozi) (PDF)   CP.PHAR.297  May 1, 2025
Finerenone (Kerendia) (PDF) CP.PMN.266 January 1, 2025
Fingolimod (Gilenya) (PDF) CP.PCH.38 Retire by July 1, 2025
Fingolimod (Gilenya) (PDF)  CP.PCH.38  July 1, 2025
Fingolimod (Gilenya, Tascenso ODT) (PDF) CP.PHAR.251 July 1, 2025
Fitusiran (Qfitlia) PDF CP.PHAR.706 June 1, 2025
Flibanserin (Addyi) (PDF) CP.PHAR.446 January 1, 2025
Fluorouracil Cream (Tolak) (PDF) CP.PMN.165 January 1, 2025
Fluticasone Propionate (Xhance) (PDF) CP.PMN.95 January 1, 2025
Fondaparinux (Arixtra) (PDF) CP.PHAR.226 April 1, 2025
Fosdenopterin (Nulibry) (PDF) CP.PHAR.471 Retire by July 1, 2025
Fosdenopterin (Nulibry) (PDF)  CP.PHAR.471  July 1, 2025
Fostamatinib (Tavalisse) (PDF)  CP.PHAR.24  April 1, 2025
Fostemsavir (Rukobia) (PDF)  CP.PHAR.516  April 1, 2025
Fremanezumab-vfrm (Ajovy)(PDF) HIM.PA.SP66 January 1, 2025
Fruquintinib (Fruzaqla) (PDF)  CP.PHAR.666  April 1, 2025
Fulvestrant (Faslodex Injection) (PDF)  CP.PHAR.424 October 1, 2024
Furosemide (Furoscix) (PDF)  CP.PHAR.608  April 1, 2025
Futibatinib (Lytgobi) (PDF)  CP.PHAR.604  April 1, 2025
Gabapentin ER (Gralise, Horizant) (PDF) CP.PMN.240 January 1, 2025
Galcanezumab-gnlm (Emgality) (PDF) HIM.PA.SP67 January 1, 2025
Galsulfase (Naglazyme) (PDF) CP.PHAR.161 Retire by July 1, 2025
Galsulfase (Naglazyme) (PDF)  CP.PHAR.161  July 1, 2025
Ganaxolone (Ztalmy) (PDF) CP.PMN.278 Retire by July 1, 2025
Ganaxolone (Ztalmy) (PDF)  CP.PMN.278  July 1, 2025
Gefitinib (Iressa) (PDF) CP.PHAR.68 Retire by July 1, 2025
Gefitinib (Iressa) (PDF)  CP.PHAR.68  July 1, 2025
Gemtuzumab Ozogamicin (Mylotarg) (PDF) CP.PHAR.358 January1, 2025
Gilteritinib (Xospata) (PDF)  CP.PHAR.412  April 1, 2025
Givinostat (Duvyzat) (PDF) CP.PHAR.644 January 1, 2025
Givosiran (Givlaari) (PDF)  CP.PHAR.457  April 1, 2025
Glasdegib (Daurismo)(PDF)  CP.PHAR.413  April 1, 2025
Glatiramer (Copaxone, Glatopa) (PDF) CP.PHAR.252 Retire by July 1, 2025
Glatiramer (Copaxone, Glatopa) (PDF)  CP.PHAR.252  July 1, 2025
Glaucoma Agents (Omlonti, Rhopressa, Rocklatan, Vyzulta) (PDF)  CP.PMN.286  April 1, 2025
Glecaprevir/Pibrentasvir (Mavyret)(PDF) HIM.PA.SP36 January 1, 2025
Glofitamab-gxbm (Columvi) (PDF) CP.PHAR.636 September 1, 2024
GLP-1 Receptor Agonists (PDF) AR.QC.PA.53 January 1, 2025
Glycerol Phenylbutyrate (Ravicti) (PDF)  CP.PHAR.207  April 1, 2025
Golodirsen (Vyondys 53) (PDF)  CP.PHAR.453  April 1, 2025
Goserelin Acetate (Zoladex) (PDF) CP.PHAR.171 Retire by June 1, 2025
Goserelin Acetate (Zoladex) (PDF)  CP.PHAR.171  June 1, 2025
Granisetron (Sancuso, Sustol) (PDF) CP.PMN.74 January 1, 2025
Halcinonide (Halog) (PDF) HIM.PA.20 January 1, 2025
Halobetasol Propionate Lotion (Bryhali, Lexette, Ultravate) (PDF) CP.PMN.180 January 1, 2025
Halobetasol Propionate/Tazarotene (Duobrii) (PDF) CP.PMN.208 January 1, 2025
Hemin (Panhematin) (PDF)  CP.PHAR.181  April 1, 2025
Histrelin Acetate (Vantas, Supprelin LA) (PDF)  CP.PHAR.172  July 1, 2025
House dust mite allergen extract (Odactra®) (PDF) CP.PMN.111 June 1, 2025
Human Growth Hormone (Somapacitan, Somatropin) (PDF)  HIM.PA.161  April 1, 2025
Hyaluronate derivatives (PDF) CP.PHAR.05 January 1, 2025
Hydroxyprogesterone Caproate (Makena) (PDF) CP.PHAR.14 Retire by July 1, 2025
Hydroxyprogesterone Caproate (Makena) (PDF)  CP.PHAR.14  July 1, 2025
Hydroxyurea (Siklos, Xromi) (PDF)  CP.PMN.193  July 1, 2025
Ibalizumab-uiyk (Trogarzo) (PDF) CP.PHAR.378 Retire by July 1, 2025
Ibalizumab-uiyk (Trogarzo) (PDF)  CP.PHAR.378  July 1, 2025
Ibandronate Injection (Boniva) (PDF)  CP.PHAR.189  April 1, 2025
Ibrutinib (Imbruvica) (PDF) CP.PHAR.126 Retire by June 1, 2025
Ibrutinib (Imbruvica) (PDF)  CP.PHAR.126  June 1, 2025
Icatibant (Firazyr®) (PDF) CP.PHAR.178 January 1, 2025
Icosapent ethyl (Vascepa) (PDF)  CP.PMN.187  April 1, 2025
Idecabtagene Vicleucel (Abecma) (PDF) CP.PHAR.481 Retire by July 1, 2025
Idecabtagene Vicleucel (Abecma) (PDF)  CP.PHAR.481  July 1, 2025
Idelalisib (Zydelig) (PDF) CP.PHAR.133 January 1, 2025
Idursulfase (Elaprase) (PDF) CP.PHAR.156 Retire by July 1, 2025
Idursulfase (Elaprase) (PDF)  CP.PHAR.156  July 1, 2025
Iloperidone (Fanapt) (PDF) CP.PMN.32 January 1, 2025
Iloprost (Ventavis®) (PDF)  CP.PHAR.193  April 1, 2025
Imatinib (Gleevec, Imkeldi) (PDF) CP.PHAR.65 Retire by July 1, 2025
Imatinib (Gleevec, Imkeldi) (PDF)  CP.PHAR.65  July 1, 2025
Imetelstat (Rytelo) (PDF) CP.PHAR.690 January 1, 2025
Imiglucerase (Cerezyme) (PDF) CP.PHAR.154 Retire by July 1, 2025
Imiglucerase (Cerezyme) (PDF)  CP.PHAR.154  July 1, 2025
Immune Globulins (PDF) CP.PHAR.103 Retire by September 1, 2025
Immune Globulins (PDF)  CP.PHAR.103  September 1, 2025
Immune Globulins for PANS/PANDAS (PDF) AR.CP.PHAR.103 February 1, 2025
Inavolisib (Itovebi) (PDF) CP.PHAR.702 January 1, 2025
Inclisiran (Leqvio) (PDF)  CP.PHAR.568  April 1, 2025
IncobotulinumtoxinA (Xeomin) (PDF) CP.PHAR.231 Retire by July 1, 2025
IncobotulinumtoxinA (Xeomin) (PDF)  CP.PHAR.231  July 1, 2025
Inebilizumab-cdon (Uplizna) (PDF) CP.PHAR.458 January 1, 2025
Inebilizumab-cdon (Uplizna) (PDF)  CP.PHAR.458 October 1, 2024
Infertility and Fertility Preservation (PDF) CP.PHAR.131 January 1, 2025
Inhaled Agents for Asthma and COPD (PDF)  HIM.PA.153  April 1, 2025
Inotersen (Tegsedi) (PDF) CP.PHAR.405 Retire by July 1, 2025
Inotersen (Tegsedi) (PDF)  CP.PHAR.405  July 1, 2025
Inotuzumab Ozogamicin (Besponsa) (PDF) CP.PHAR.359 January1, 2025
Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF)    CP.PHAR.534  July 1, 2025
Insulin Detemir (Levemir) (PDF) HIM.PA.171 Retire by June 1, 2025
Insulin Detemir (Levemir) (PDF)  HIM.PA.171  June 1, 2025
Insulin Glargine (Basaglar, Rezvoglar, Toujeo, unbranded Semglee) (PDF)   HIM.PA.09  April 1, 2025
Interferon Beta-1a (Avonex, Rebif) (PDF) CP.PHAR.255 Retire by July 1, 2025
Interferon Beta-1a (Avonex, Rebif) (PDF)  CP.PHAR.255  July 1, 2025
Interferon beta-1b (Betaseron, Extavia) (PDF) CP.PCH.46 Retire by July 1, 2025
Interferon beta-1b (Betaseron, Extavia) (PDF)  CP.PCH.46  July 1, 2025
Interferon Gamma- 1b (Actimmune) (PDF)  CP.PHAR.52  April 1, 2025
Iobenguane I-131 (Azedra) (PDF)  CP.PHAR.459  April 1, 2025
Ipilimumab (Yervoy) (PDF) CP.PHAR.319 Retire by September 1, 2025
Ipilimumab (Yervoy) (PDF)  CP.PHAR.319  September 1, 2025
Iptacopan (Fabhalta) (PDF) CP.PHAR.656 Retire by July 1, 2025
Iptacopan (Fabhalta) (PDF)  CP.PHAR.656  July 1, 2025
Irinotecan Liposome (Onivyde) (PDF) CP.PHAR.304 January1, 2025
Isatuximab-irfc (Sarclisa) (PDF) CP.PHAR.482 Retire by July 1, 2025
Isatuximab-irfc (Sarclisa) (PDF)  CP.PHAR.482  July 1, 2025
Isavuconazonium (Cresemba) (PDF) CP.PMN.154 Retire by July 1, 2025
Isavuconazonium (Cresemba) (PDF)  CP.PMN.154  July 1, 2025
Isotretinoin (Claravis Absorica Absorica LD Myorisan Zenatane Amnesteem) (PDF) CP.PMN.143 March 1, 2025
Istradefylline (Nourianz) (PDF)  CP.PMN.217  April 1, 2025
Itraconazole (Sporanox, Onmel) (PDF) CP.PMN.124 Retire by July 1, 2025
Itraconazole (Sporanox, Onmel) (PDF)  CP.PMN.124  July 1, 2025
Ivabradine (Corlanor) (PDF) CP.PMN.70 Retire by June 1, 2025
Ivabradine (Corlanor) (PDF)  CP.PMN.70  June 1, 2025
Ivacaftor (Kalydeco) (PDF)  CP.PHAR.210  April 1, 2025
Ivermectin (Stromectol, Sklice) (PDF) CP.PMN.269 January 1, 2025
Ivosidenib (Tibsovo) (PDF) CP.PHAR.137 January 1, 2025
Ixazomib (Ninlaro) (PDF) CP.PHAR.302 January 1, 2025
Ketamine (Ketalar) (PDF) CP.PMN.296 September 1, 2024
Ketorolac nasal spray (Sprix) (PDF) CP.PMN.282 January 1, 2025
Lanadelumab-fylo (Takhzyro) (PDF) HIM.PA.172 May 1, 2024
Lanreotide (Somatuline Depot and Unbranded) (PDF) CP.PHAR.391 January1, 2025
Lapatinib (Tykerb®) (PDF) CP.PHAR.79 January 1, 2025
Laronidase (Aldurazyme) (PDF) CP.PHAR.152 Retire by July 1, 2025
Laronidase (Aldurazyme) (PDF)  CP.PHAR.152  July 1, 2025
Larotrectinib (Vitrakvi)(PDF)  CP.PHAR.414  April 1, 2025
Lasmiditan (Reyvow) (PDF) CP.PMN.218 Retire by June 1, 2025
Lasmiditan (Reyvow) (PDF)  CP.PMN.218  June 1, 2025
Lazertinib (Lazcluze) (PDF) CP.PHAR.695 January 1, 2025
Lebrikizumab (Ebglyss) (PDF)  CP.PHAR.704 January 1, 2025
Lecanemab-irmb (Leqembi) (PDF) CP.PHAR.596 Retire by July 1, 2025
Lecanemab-irmb (Leqembi) (PDF)  CP.PHAR.596  July 1, 2025
Ledipasvir-Sofosbuvir (Harvoni) (PDF) HIM.PA.SP3 January 1, 2025
Lefamulin (Xenleta) (PDF) CP.PMN.219 September 1, 2024
Lenacapavir (Sunlenca) (PDF) CP.PHAR.622 Retire by July 1, 2025
Lenacapavir (Sunlenca) (PDF)  CP.PHAR.622  July 1, 2025
Lenalidomide (Revlimid) (PDF) CP.PHAR.71 Retire by September 1, 2025
Lenalidomide (Revlimid) (PDF)  CP.PHAR.71  September 1, 2025
Leniolisib (Joenja) (PDF) CP.PHAR.597 January 1, 2025
Lenvatinib (Lenvima) (PDF)  CP.PHAR.138  May 1, 2025
Letermovir (Prevymis) (PDF)  CP.PHAR.367  April 1, 2025
Leucovorin Injection (PDF) CP.PHAR.393 May 1, 2024
Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF) CP.PHAR.173 May 1, 2024
Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF) CP.PCH.53 Retire by June 1, 2025
Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF)   CP.PCH.53  June 1, 2025
Levodopa Inhalation Powder (Inbrija) (PDF) CP.PMN.267 January 1, 2025
Levoketoconazole (Recorlev) (PDF) CP.PMN.275 Retire by July 1, 2025
Levoketoconazole (Recorlev) (PDF)  CP.PMN.275  July 1, 2025
Levoleucovorin (Fusilev, Khapzory) (PDF) CP.PHAR.151 January 1, 2025
Levomilnacipran (Fetzima) (PDF) HIM.PA.125 January 1, 2025
L-glutamine (Endari) (PDF) CP.PMN.116 January 1, 2025
Lidocaine Transdermal (Lidoderm, ZTlido) (PDF) CP.PMN.08 January 1, 2025
Lifileucel (Amtagvi) (PDF) CP.PHAR.598 January 1, 2025
Lifitegrast (Xiidra®) (PDF)  CP.PMN.73  April 1, 2025
Linezolid (Zyvox) (PDF) CP.PMN.27 August 1, 2024
Lisocabtagene Maraleucel (Breyanzi) (PDF) CP.PHAR.483 Retire by July 1, 2025
Lisocabtagene Maraleucel (Breyanzi) (PDF)  CP.PHAR.483  July 1, 2025
Lofexidine (Lucemyra) (PDF) CP.PMN.152 Retire by June 1, 2025
Lofexidine (Lucemyra) (PDF)  CP.PMN.152  June 1, 2025
Lomustine (Gleostine) (PDF) CP.PHAR.507 January 1, 2025
Lonafarnib (Zokinvy) (PDF)  CP.PHAR.499  April 1, 2025
Loncastuximab Tesirine-lpyl (Zynlonta) (PDF) CP.PHAR.539 September 1, 2024
Lorlatinib (Lorbrena)(PDF) CP.PHAR.406 Retire by September 1, 2025
Lorlatinib (Lorbrena)(PDF)  CP.PHAR.406  September 1, 2025
Loteprednol etabonate (Eysuvis) (PDF)  CP.PMN.260  April 1, 2025
Lotilaner (Xdemvy) (PDF) CP.PMN.291 January 1, 2025
Lovotibeglogene Autotemcel (Lyfgenia) (PDF) CP.PHAR.627 Retire by June 1, 2025
Lovotibeglogene Autotemcel (Lyfgenia) (PDF)  CP.PHAR.627  June 1, 2025
Lubiprostone (Amitiza) (PDF) CP.PMN.142 January 1, 2025
Luliconazole Cream (Luzu) (PDF)  CP.PMN.166  April 1, 2025
Lumacaftor-Ivacaftor (Orkambi) (PDF)  CP.PHAR.213  April 1, 2025
Lumasiran (Oxlumo) (PDF)  CP.PHAR.473  April 1, 2025
Lumateperone (Caplyta) (PDF) CP.PMN.232 January 1, 2025
Lurbinectedin (Zepzelca) (PDF) CP.PHAR.500 September 1, 2024
Luspatercept-aamt (Reblozyl) (PDF)  CP.PHAR.450  April 1, 2025
Lusutrombopag (Mulpleta)(PDF)  CP.PHAR.407  April 1, 2025
Lutetium Lu 177 dotatate (Lutathera) (PDF) CP.PHAR.384 September 1, 2024
Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (PDF) CP.PHAR.582 Retire by July 1, 2025
Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (PDF)  CP.PHAR.582  July 1, 2025
Macitentan (Opsumit) (PDF)  CP.PHAR.194  April 1, 2025
Mannitol (Bronchitol) (PDF) CP.PHAR.518 January 1, 2025
Maralixibat (Livmarli) (PDF) CP.PHAR.543 January 1, 2025
Margetuximab-cmkb (Margenza) (PDF)  CP.PHAR.522  April 1, 2025
Maribavir (Livtencity) (PDF)  CP.PMN.271  April 1, 2025
Marstacimab-hncq (Hympavzi) (PDF) CP.PHAR.674 June 1, 2025
Mavacamten (Camzyos) (PDF) CP.PMN.272 January 1, 2025
Mavorixafor (Xolremdi) CP.PHAR.679 Retire by July 1, 2025
Mavorixafor (Xolremdi)  CP.PHAR.679  July 1, 2025
Mecamylamine (Vecamyl) (PDF) CP.PMN.136 Retire by July 1, 2025
Mecamylamine (Vecamyl) (PDF)  CP.PMN.136  July 1, 2025
Mecasermin (Increlex) (PDF) CP.PHAR.150 October 1, 2024
Megestrol Acetate (PDF) CP.PMN.179 January 1, 2025
Melphalan (Hepzato) (PDF) CP.PHAR.653 January 1, 2025
Melphalan flufenamide (Pepaxto) (PDF) CP.PHAR.535 Retire by July 1, 2025
Melphalan flufenamide (Pepaxto) (PDF)  CP.PHAR.535  July 1, 2025
Memantine (Namenda XR, Namzaric) (PDF) CP.PCH.30 January 1, 2025
Mepolizumab (Nucala) (PDF) CP.PHAR.200 January 1, 2025
Mercaptopurine (Purixan) (PDF) CP.PHAR.447 Retire by July 1, 2025
Mercaptopurine (Purixan) (PDF)  CP.PHAR.447  July 1, 2025
Metformin ER (Glumetza, Fortamet) (PDF)  CP.PMN.72  April 1, 2025
Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo) (PDF) CP.PHAR.134 January 1, 2025
Methoxsalen (Uvadex) (PDF) HIM.PA.17 January 1, 2025
Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF) CP.PHAR.238 Retire by September 1, 2025
Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF)  CP.PHAR.238  September 1, 2025
Methylnaltrexone Bromide (Relistor) (PDF) CP.PMN.169 January 1, 2025
Metoclopramide (Gimoti) (PDF) CP.PMN.252 January 1, 2025
Metreleptin (Myalept) (PDF) CP.PHAR.425 September 1, 2024
Midazolam (Nayzilam) (PDF) CP.PMN.211 January 1, 2025
Midostaurin (Rydapt) (PDF) CP.PHAR.344 Retire by July 1, 2025
Midostaurin (Rydapt) (PDF)  CP.PHAR.344  July 1, 2025
Mifepristone (Korlym) (PDF) CP.PHAR.101 Retire by June 1, 2025
Mifepristone (Korlym) (PDF)  CP.PHAR.101  June 1, 2025
Migalastat (Galafold) (PDF) CP.PHAR.394 Retire by July 1, 2025
Migalastat (Galafold) (PDF)  CP.PHAR.394  July 1, 2025
Miglustat (Zavesca) (PDF)  CP.PHAR.164  September 1, 2025
Milnacipran (Savella) (PDF) CP.PMN.125 Retire by September 1, 2025
Milnacipran (Savella) (PDF)  CP.PMN.125  September 1, 2025
Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF) CP.PMN.80 Retire by July 1, 2025
Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF)   CP.PMN.80  July 1, 2025
Mirdametinib (Gomekli) (PDF) CP.PHAR.718 July 1, 2025
Mirvetuximab soravatansine-gynx (Elahere) (PDF)   CP.PHAR.617  April 1, 2025
Mitapivat (Pyrukynd) (PDF) CP.PHAR.558 January 1, 2025
Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF) CP.PHAR.495 September 1, 2024
Mitoxantrone (PDF) CP.PHAR.258 Retire by July 1, 2025
Mitoxantrone (PDF)  CP.PHAR.258  July 1, 2025
Mixed pollens allergen extract (Oralair) (PDF) CP.PMN.85 January 1, 2025
Mobocertinib (Exkivity) (PDF) CP.PHAR.559 January 1, 2025
Modafinil (Provigil) (PDF) CP.PMN.39 Retire by July 1, 2025
Modafinil (Provigil) (PDF)  CP.PMN.39  July 1, 2025
Mogamulizumab-kpkc (Poteligeo) (PDF) CP.PHAR.139 March 1, 2025
Momelotinib (Ojjaara) (PDF) CP.PHAR.654 January 1, 2025
Mometasone (Nasonex) (PDF) HIM.PA.93 January 1, 2025
Mometasone Furoate (Sinuva) (PDF) CP.PHAR.448 August 1, 2024
Mosunetuzumab-axgb (Lunsumio) (PDF)  CP.PHAR.618  April 1, 2025
Motixafortide (Aphexda) (PDF) CP.PHAR.655 January 1, 2025
Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF) CP.PHAR.398 January 1, 2025
Nabumatone Double-Strength (Relafen DS) (PDF) CP.PMN.287 Retire by July 1, 2025
Nabumatone Double-Strength (Relafen DS) (PDF)  CP.PMN.287  July 1, 2025
Nadofaragene Firadenovec-vncg (Adstiladrin) (PDF) CP.PHAR.461 March 1, 2025
Nafarelin acetate (Synarel®) (PDF)  CP.PHAR.174  July 1, 2025
Naldemedine (Symproic) (PDF) CP.PMN.112 January 1, 2025
Nalmefene (Opvee, Zurnai) (PDF) CP.PHAR.638 January 1, 2025
Naloxegol (Movantik) (PDF) HIM.PA.167 January 1, 2025
Naproxen/Esomeprazole (Vimovo) (PDF) CP.PMN.117 July 1, 2025
Naproxen oral suspension (Naprosyn) (PDF) HIM.PA.130 January 1, 2025
Natalizumab (Tysabri) (PDF) CP.PHAR.259 Retire by July 1, 2025
Natalizumab (Tysabri) (PDF)  CP.PHAR.259  July 1, 2025
Naxitamab-gqgk (Danyelza) (PDF)  CP.PHAR.523  April 1, 2025
Necitumumab (Portrazza) (PDF) CP.PHAR.320 January 1, 2025
Nedosiran (Rivfloza) (PDF)  CP.PHAR.619  April 1, 2025
Nemolizumab-ito (Nemluvio) (PDF) CP.PHAR.703 Retire by June 1, 2025
Nemolizumab-ito (Nemluvio) (PDF)  CP.PHAR.703  June 1, 2025
Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF) CP.PMN.167 January 1, 2025
Neratinib (Nerlynx) (PDF) CP.PHAR.365 January 1, 2025
Netupitant and Palonosetron (Akynzeo) (PDF) CP.PMN.158 January 1, 2025
Nifurtimox (Lampit)  (PDF) CP.PMN.256 January 1, 2025
Nilotinib (Tasigna, Danziten) (PDF) CP.PHAR.76 Retire by July 1, 2025
Nilotinib (Tasigna, Danziten) (PDF)  CP.PHAR.76  July 1, 2025
Nintedanib (Ofev) (PDF) CP.PHAR.285 January 1, 2025
Niraparib (Zejula) (PDF)  CP.PHAR.408  April 1, 2025
Niraparib and Abiraterone (Akeega) (PDF) CP.PHAR.645 January 1, 2025
Nirmatrelvir-Ritonavir (Paxlovid) (PDF) CP.PMN.288 January 1, 2025
Nirogacestat (Ogsiveo) (PDF)  CP.PHAR.671  April 1, 2025
Nirsevimab-alip (Beyfortus) (PDF) CP.PHAR.614 September 1, 2024
Nitazoxanide (Alinia) (PDF) HIM.PA.152 January 1, 2025
Nitisinone (Nityr, Orfadin) (PDF) CP.PHAR.132 January 1, 2025
Nivolumab, Nivolumab Hyaluronidase-nvhy (Opdivo, Opdivo Qvantig) Nivolumab (Opdivo) (PDF) CP.PHAR.121 Retire by September 1, 2025
Nivolumab, Nivolumab Hyaluronidase-nvhy (Opdivo, Opdivo Qvantig) Nivolumab (Opdivo) (PDF) CP.PHAR.121  September 1, 2025
Nivolumab and Relatlimab-rmbw (Opdualag) (PDF) CP.PHAR.588 September 1, 2024
No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF) HIM.PA.33 January 1, 2025
Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF) CP.PHAR.684 January 1, 2025
Non-Calcium Phosphate Binders (Auryxia, Fosrenol, Renagel, Renvela, Velphoro) (PDF) CP.PMN.04 Retire by June 1, 2025
Non-Calcium Phosphate Binders (Auryxia, Fosrenol, Renagel, Renvela, Velphoro) (PDF)   CP.PMN.04  June 1, 2024
Non-Formulary and Formulary Contraceptives (PDF) HIM.PA.100 Retire by July 1, 2025
Non-Formulary and Formulary Contraceptives (PDF)  HIM.PA.100  July 1, 2025
Non-Formulary Test Strips (PDF)  HIM.PA.34  April 1, 2025
Nusinersen (Spinraza) (PDF)  CP.PHAR.327  July 1, 2025
Obecabtagene autoleucel (Aucatzyl) (PDF) CP.PHAR.675 June 1, 2025
Obeticholic acid (Ocaliva) (PDF) CP.PHAR.287 January 1, 2025
Obinutuzumab (Gazyva) (PDF) CP.PHAR.305 January 1, 2025
Ocrelizumab (Ocrevus) (PDF) CP.PHAR.335 Retire by July 1, 2025
Ocrelizumab (Ocrevus) (PDF)  CP.PHAR.335  July 1, 2025
Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF) CP.PHAR.40 Retire by June 1, 2025
Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF)   CP.PHAR.40  June 1, 2025
Odevixibat (Bylvay) (PDF) CP.PHAR.528 Retire by September 1, 2025
Odevixibat (Bylvay) (PDF)  CP.PHAR.528  September 1, 2025
Ofatumumab (Arzerra, Kesimpta) (PDF) CP.PHAR.306 Retire by September 1, 2025
Ofatumumab (Arzerra, Kesimpta) (PDF)  CP.PHAR.306  September 1, 2025
Off-Label Drug Use (PDF) HIM.PA.154 January 1, 2025
Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF) CP.PHAR.292 May 1, 2024
Olanzapine-samidorphan (Lybalvi) (PDF) CP.PMN.265 January 1, 2025
Olaparib (Lynparza) (PDF)  CP.PHAR.360  April 1, 2025
Olezarsen (Tryngolza) (PDF) CP.PHAR.689 April 1, 2025
Olipudase Alfa-rpcp (Xenpozyme) (PDF) CP.PHAR.586 September 1, 2024
Olutasidenib (Rezlidhia) (PDF)  CP.PHAR.615  April 1, 2025
Omacetaxine (Synribo) (PDF) CP.PHAR.108 Retire by September 1, 2024
Omacetaxine (Synribo) (PDF)  CP.PHAR.108  September 1, 2025
Omadacycline (Nuzyra) (PDF) CP.PMN.188 September 1, 2024
Omalizumab (Xolair) (PDF) CP.PCH.49 June 1, 2025
Omaveloxolone (Skyclarys) (PDF) CP.PHAR.590 Retire by July 1, 2025
Omaveloxolone (Skyclarys) (PDF)  CP.PHAR.590  July 1, 2025
OnabotulinumtoxinA (Botox) (PDF) CP.PHAR.232 Retire by July 1, 2025
OnabotulinumtoxinA (Botox) (PDF)  CP.PHAR.232 July 1, 2025
Onasemnogene Abeparvovec (Zolgensma) (PDF) CP.PHAR.421 Retire by July 1, 2025
Onasemnogene Abeparvovec (Zolgensma) (PDF)  CP.PHAR.421  July 1, 2025
Ophthalmic Corticosteroids (PDF) HIM.PA.03 January 1, 2025
Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF) CP.PHAR.536 Retire by July 1, 2025
Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF)  CP.PHAR.536  July 1, 2025
Opicapone (Ongentys) (PDF) CP.PMN.245 January 1, 2025
Opioid Analgesics (PDF) HIM.PA.139 Retire by July 1, 2025
Opioid Analgesics (PDF)  HIM.PA.139  July 1, 2025
Osilodrostat (Isturisa) (PDF) CP.PHAR.487 January 1, 2025
Osimertinib (Tagrisso) (PDF) CP.PHAR.294 Retire by July 1, 2025
Osimertinib (Tagrisso) (PDF)  CP.PHAR.294  July 1, 2025
Ospemifene (Osphena) (PDF) CP.PMN.168 January 1, 2025
Overactive Bladder Agents (PDF)   CP.PMN.198   September 1, 2025
Oxymetazoline (Rhofade, Upneeq) (PDF) CP.PMN.86 Retire by July 1, 2025
Oxymetazoline (Rhofade, Upneeq) (PDF)  CP.PMN.86  July 1, 2025
Ozanimod (Zeposia) (PDF) CP.PHAR.462 Retire by July 1, 2025
Ozanimod (Zeposia) (PDF)  CP.PHAR.462  July 1, 2025
Ozenoxacin (Xepi) (PDF) CP.PMN.119 Retire by July 1, 2025
Ozenoxacin (Xepi) (PDF)  CP.PMN.119  July 1, 2025
Paclitaxel, Protein-Bound (Abraxane) (PDF) CP.PHAR.176 Retire by July 1, 2025
Paclitaxel, Protein-Bound (Abraxane) (PDF)   CP.PHAR.176  July 1, 2025
Pacritinib (Vonjo) (PDF) CP.PHAR.583 Retire by July 1, 2025
Pacritinib (Vonjo) (PDF)  CP.PHAR.583  July 1, 2025
Palbociclib (Ibrance) (PDF) HIM.PA.173 January 1, 2025
Paliperidone Long-Acting Injections (Invega Hafyera, Invega Sustenna, Invega Trinza) (PDF) CP.PHAR.291 Retire by May 1, 2025
Paliperidone Long-Acting Injections (Invega Hafyera, Invega Sustenna, Invega Trinza) (PDF)   CP.PHAR.291  May 1, 2025
Palivizumab (Synagis) (PDF) CP.PHAR.16 Retire by July 1, 2025
Palivizumab (Synagis) (PDF)  CP.PHAR.16  July 1, 2025
Palopegteriparatide (Yorvipath) (PDF) CP.PHAR.696 January 1, 2025
Palovarotene (PDF) CP.PHAR.548 January 1, 2025
Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep) (PDF) CP.PCH.44 March 1, 2025
Panitumumab (Vectibix) (PDF)  CP.PHAR.321  May 1, 2025
Parathyroid Hormone (Natpara) (PDF)  CP.PHAR.282  April 1, 2025
Paricalcitol Injection (Zemplar) (PDF) CP.PHAR.270 September 1, 2024
Pasireotide (Signifor, Signifor LAR) (PDF) CP.PHAR.332 January1, 2025
Patiromer (Veltassa) (PDF) CP.PMN.205 January 1, 2025
Patisiran (Onpattro) (PDF) CP.PHAR.395 Retire by July 1, 2025
Patisiran (Onpattro) (PDF)  CP.PHAR.395  July 1, 2025
Pazopanib (Votrient) (PDF) CP.PHAR.81 January 1, 2025
Peanut allergen powder (Palforzia) (PDF) CP.PMN.220 January 1, 2025
Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (PDF) CP.PHAR.353 March 1, 2025
Pegcetacoplan (Empaveli, APL-2) (PDF)  CP.PHAR.524 October 1, 2024
Pegfilgrastim/Biosimilars, Eflapegrastim, Efbemalenograstim (PDF) CP.PHAR.296 January 1, 2025
Peginterferon Alfa-2a (Pegasys) (PDF) CP.PHAR.89 January 1, 2025
Peginterferon beta-1a (Plegridy) (PDF) CP.PHAR.271 Retire by July 1, 2025
Peginterferon beta-1a (Plegridy) (PDF)  CP.PHAR.271  July 1, 2025
Pegloticase (Krystexxa) (PDF)  CP.PHAR.115  April 1, 2025
Pegunigalsidase Alfa-iwxj (Elfabrio) (PDF) CP.PHAR.512 Retire by September 1, 2025
Pegunigalsidase Alfa-iwxj (Elfabrio) (PDF)  CP.PHAR.512  September 1, 2025
Pegvaliase-pqpz (Palynziq) (PDF) CP.PHAR.140 March 1, 2025
Pegvisomant (Somavert) (PDF) CP.PHAR.389 January 1, 2025
Pembrolizumab (Keytruda®) (PDF)  CP.PHAR.322  Retire by September 1, 2025
Pembrolizumab (Keytruda®) (PDF)   CP.PHAR.322   September 1, 2025
Pemetrexed (Alimta, Pemfexy) (PDF) CP.PHAR.368 Retire by June 1, 2025
Pemetrexed (Alimta, Pemfexy, Axtle) (PDF)  CP.PHAR.368 June 1, 2025
Pemigatinib (Pemazyre) (PDF) CP.PHAR.496 January 1, 2025
Penicillamine (Cuprimine) (PDF) CP.PCH.09 January 1, 2025
Perampanel (Fycompa) (PDF) CP.PMN.156 January 1, 2025
Perfluorohexyloctane (Miebo) (PDF) CP.PMN.290 January 1, 2025
Pertuzumab (Perjeta) (PDF) CP.PHAR.227 Retire by September 1, 2024
Pertuzumab (Perjeta) (PDF)  CP.PHAR.227  September 1, 2025
Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (PDF) CP.PHAR.501 September 1, 2024
Pexidartinib (Turalio)(PDF) CP.PHAR.436 January 1, 2025
Phendimetrazine (PDF) CP.PCH.47 Retire by July 1, 2025
Phendimetrazine (PDF)  CP.PCH.47  July 1, 2025
Phentermine (Adipex-P, Lomaira) (PDF) CP.PCH.13 Retire by July 1, 2025
Phentermine (Adipex-P, Lomaira) (PDF)  CP.PCH.13  July 1, 2025
Pilocarpine (Vuity) (PDF) CP.PMN.270 January 1, 2025
Pimavanserin (Nuplazid) (PDF) CP.PMN.140 January 1, 2025
Pirfenidone (Esbriet) (PDF)  CP.PHAR.286  April 1, 2025
Pirtobrutinib (Jaypirca) (PDF) CP.PHAR.620 Retire by July 1, 2025
Pirtobrutinib (Jaypirca) (PDF)  CP.PHAR.620  July 1, 2025
Pitolisant (Wakix) (PDF) CP.PMN.221 Retire by July 1, 2025
Pitolisant (Wakix) (PDF)  CP.PMN.221  July 1, 2025
Plasminogen, human-tvmh (Ryplazim) (PDF) CP.PHAR.513 January1, 2025
Plecanatide (Trulance) (PDF) CP.PMN.87 January 1, 2025
Plerixafor (Mozobil) (PDF)  CP.PHAR.323 October 1, 2024
Polatuzumab Vedotin-piiq (Polivy) (PDF) CP.PHAR.433 September 1, 2024
Pomalidomide (Pomalyst) (PDF) CP.PHAR.116 Retire by July 1, 2025
Pomalidomide (Pomalyst) (PDF)  CP.PHAR.116  July 1, 2025
Ponatinib (Iclusig) (PDF) CP.PHAR.112 Retire by July 1, 2025
Ponatinib (Iclusig) (PDF)  CP.PHAR.112  July 1, 2025
Ponesimod (Ponvory) (PDF) CP.PHAR.537 Retire by July 1, 2025
Ponesimod (Ponvory) (PDF)  CP.PHAR.537  July 1, 2025
Potassium Chloride for Oral Solution (Klor-Con Powder) (PDF)  HIM.PA.143  April 1, 2025
Pozelimab-bbfg (Veopoz) (PDF) CP.PHAR.626 Retire by September 1, 2025
Pozelimab-bbfg (Veopoz) (PDF)  CP.PHAR.626  September 1, 2025
Pralatrexate (Folotyn) (PDF) CP.PHAR.313 March 1, 2025
Pramlintide (Symlin) (PDF)  CP.PMN.129  April 1, 2025
Prasterone (Intrarosa) (PDF)  CP.PMN.99  April 1, 2025
Pregabalin (Lyrica) (PDF) CP.PMN.33 Retire by July 1, 2025
Pregabalin (Lyrica) (PDF)  CP.PMN.33  July 1, 2025
Pretomanid (PDF)  CP.PMN.222  April 1, 2025
Progesterone (Crinone, Endometrin, Milprosa) (PDF) CP.PMN.243 January 1, 2025
Propranolol (Hemangeol) (PDF) CP.PCH.51 Retire by July 1, 2025
Propranolol (Hemangeol) (PDF)  CP.PCH.51  July 1, 2025
Protein C Concentrate, Human (Ceprotin) (PDF)  CP.PHAR.330  April 1, 2025
Prucalopride (Motegrity) (PDF)  HIM.PA.159  September 1, 2025
Pyrimethamine (Daraprim®) (PDF) CP.PMN.44 January 1, 2025
Quantity Limit Override and Dose Optimization (PDF) CP.PMN.59 January 1, 2025
Quetiapine ER (Seroquel XR) (PDF)  CP.PMN.64  April 1, 2025
Quinine Sulfate (Qualaquin) (PDF) CP.PMN.262 Retire by July 1, 2025
Quinine Sulfate (Qualaquin) (PDF)  CP.PMN.262  July 1, 2025
Quizartinib (Vanflyta) (PDF) CP.PHAR.646 January 1, 2025
Ramucirumab (Cyramza) (PDF)  CP.PHAR.119  April 1, 2025
Ranibizumab (Byooviz, Cimerli, Lucentis, Susvimo) (PDF)   CP.PHAR.186   May 1, 2025
Rasagiline (Azilect®) (PDF) HIM.PA.89 January 1, 2025
Ravulizumab-cwvz (Ultomiris) (PDF)  CP.PHAR.415 October 1, 2024
Regorafenib (Stivarga) (PDF) CP.PHAR.107 Retire by July 1, 2025
Regorafenib (Stivarga) (PDF)  CP.PHAR.107  July 1, 2025
Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (PDF) CP.PHAR.529 Retire by July 1, 2025
Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (PDF)  CP.PHAR.529  July 1, 2025
Remestemcel-L (Ryoncil) (PDF) CP.PHAR.474 July 1, 2025
Remetirom (Rezdiffra) (PDF) CP.PHAR.647 January 1, 2025
Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (PDF) HIM.PA.168 Retire by September 1, 2025
Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (PDF)   HIM.PA.168  September 1, 2025
Repotrectinib (Augtyro) (PDF)  CP.PHAR.667  April 1, 2025
Reslizumab (Cinqair) (PDF)  CP.PHAR.223  April 1, 2025
Respiratory syncytial virus vaccine (Abrysvo) (PDF) CP.PHAR.658 January 1, 2025
Retifanlimab-dlwr (Zynyz) (PDF) CP.PHAR.629 Retire by July 1, 2025
Retifanlimab-dlwr (Zynyz) (PDF)  CP.PHAR.629  July 1, 2025
Revakinagene Taroretcel-lwey (Encelto) (PDF) CP.PHAR.697 July 1, 2025
Revumenib (Revuforj) (PDF) CP.PHAR.707 April 1, 2025
Ribavirin (Copegus, Moderiba, Rebetol, Ribasphere) (PDF) CP.PHAR.141 January 1, 2025
Ribociclib (Kisqali, Kisqali Femara) (PDF) CP.PHAR.334 March 1, 2025
Rifabutin (Mycobutin) (PDF)  CP.PMN.223  April 1, 2025
Rifamycin (Aemcolo) (PDF) CP.PMN.196 Retire by July 1, 2025
Rifamycin (Aemcolo) (PDF)  CP.PMN.196  July 1, 2025
Rifaximin (Xifaxan®) (PDF) CP.PMN.47 January 1, 2025
Rilonacept (Arcalyst) (PDF) CP.PHAR.266 Retire by September 1, 2025
Rilonacept (Arcalyst) (PDF)  CP.PHAR.266  September 1, 2025
RimabotulinumtoxinB (Myobloc) (PDF) CP.PHAR.233 Retire by July 1, 2025
RimabotulinumtoxinB (Myobloc) (PDF)  CP.PHAR.233  July 1, 2025
Rimegepant (Nurtec ODT) (PDF) CP.PHAR.490 January 1, 2025
Riociguat (Adempas®) (PDF)  CP.PHAR.195  April 1, 2025
Ripretinib (Qinlock) (PDF) CP.PHAR.502 January 1, 2025
Risdiplam (Evrysdi) (PDF)  CP.PHAR.477  July 1, 2025
Risedronate (Actonel, Atelvia) (PDF) CP.PMN.100 Retire by June 1, 2025
Risedronate (Actonel, Atelvia) (PDF)  CP.PMN.100  June 1, 2025
Risperidone Long-Acting Injection (Perseris, Risperdal Consta, Rykindo, Uzedy) (PDF) CP.PHAR.293 May 1, 2024
Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (PDF) CP.PHAR.260 Retire by September 1, 2025
Rituximab (Rituxan), Rituximab-arrx (Riabni), Rituximab-pvvr (Ruxience), Rituximab-abbs (Truxima), Rituximab-Hyaluronidase (Rituxan Hycela) (PDF)   CP.PHAR.260  September 1, 2025
Roflumilast (Daliresp, Zoryve) (PDF) CP.PMN.46 January 1, 2025
Rolapitant (Varubi) (PDF) CP.PMN.102 January 1, 2025
Romidepsin (Istodax) (PDF) CP.PHAR.314 January1, 2025
Romiplostim (Nplate) (PDF)  CP.PHAR.179  April 1, 2025
Romosozumab-aqqg (Evenity) (PDF)  CP.PHAR.428  April 1, 2025
Ropeginterferon Alfa-2b-njft (BESREMi) (PDF)  CP.PHAR.570  April 1, 2025
Rozanolixizumab-noli (Rystiggo) (PDF) CP.PHAR.648 March 1, 2025
Rucaparib (Rubraca®) (PDF)  CP.PHAR.350  April 1, 2025
Rufinamide (Banzel) (PDF) CP.PMN.157 January 1, 2025
Ruxolitinib (Jakafi) (PDF)  CP.PHAR.98  April 1, 2025
Sacituzumab Govitecan-hziy (Trodelvy) (PDF)  CP.PHAR.475  July 1, 2025
Sacubitril/Valsartan (Entresto) (PDF)  CP.PCH.52  April 1, 2025
Safinamide (Xadago) (PDF)  CP.PMN.113  April 1, 2025
Sapropterin Dihydrochloride (Kuvan, Javygtor) (PDF) CP.PHAR.43 Retire by September 1, 2025
Sapropterin Dihydrochloride (Kuvan, Javygtor) (PDF)  CP.PHAR.43  September 1, 2025
Sarecycline (Seysara) (PDF)  CP.PMN.189  April 1, 2025
Sargramostim (Leukine) (PDF) CP.PHAR.295 October 1, 2024
Satralizumab-mwge (Enspryng) (PDF)  CP.PHAR.463 October 1, 2024
Sebelipase Alfa (Kanuma) (PDF) CP.PHAR.159 Retire by July 1, 2025
Sebelipase Alfa (Kanuma) (PDF)  CP.PHAR.159  July 1, 2025
Secnidazole (Solosec) (PDF)  CP.PMN.103  April 1, 2025
Seladelpar (Livdelzi) (PDF) CP.PHAR.698 January 1, 2025
Selexipag (Uptravi®) (PDF)  CP.PHAR.196  April 1, 2025
Selinexor (Xpovio) (PDF) CP.PHAR.431 June 1, 2025
Selpercatinib (Retevmo) (PDF) CP.PHAR.478 Retire by July 1, 2025
Selpercatinib (Retevmo) (PDF)  CP.PHAR.478  July 1, 2025
Selumetinib (Koselugo) (PDF) CP.PHAR.464 Retire by June 1, 2025
Selumetinib (Koselugo) (PDF)  CP.PHAR.464  June 1, 2025
Semaglutide (Wegovy) (PDF) CP.PMN.295 Retire by July 1, 2025
Semaglutide (Wegovy) (PDF)  CP.PMN.295  July 1, 2025
Semaglutide (Wegovy) - FEHB Members Only (PDF) QR.QC.CP.352 January 1, 2025
Sepsis Diagnosis (PDF) CC.PP.073 November 1, 2024
Setmelanotide (Imcivree) (PDF)  CP.PHAR.491  July 1, 2025
Short ragweed pollen allergen extract (Ragwitek) (PDF) CP.PMN.83 January 1, 2025
Sildenafil (Revatio®) (PDF)  CP.PHAR.197  April 1, 2025
Sildenafil (Viagra) (PDF) CP.PCH.07 Retire by July 1, 2025
Sildenafil (Viagra) (PDF)  CP.PCH.07  July 1, 2025
Siltuximab (Sylvant) (PDF)  CP.PHAR.329  April 1, 2025
Siponimod (Mayzent) (PDF) CP.PHAR.427 Retire by July 1, 2025
Siponimod (Mayzent) (PDF)  CP.PHAR.427  July 1, 2025
Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (PDF)   CP.PHAR.574  April 1, 2025
Sodium Oxybate (Xyrem, Lumryz) and Calcium Magnesium Potassium Sodium Oxybate (Xywav) (PDF) CP.PMN.42 Retire by July 1, 2025
Sodium Oxybate (Xyrem, Lumryz) and Calcium Magnesium Potassium Sodium Oxybate (Xywav) (PDF)   CP.PMN.42  July 1, 2025
Sodium Phenylbutyrate (Buphenyl) (PDF)  CP.PHAR.208  April 1, 2025
Sodium Phenylbutyrate-Taurursodiol (Relyvrio) (PDF) CP.PHAR.584 Retire by July 1, 2025
Sodium Phenylbutyrate-Taurursodiol (Relyvrio) (PDF)  CP.PHAR.584  July 1, 2025
Sodium thiosulfate (Pedmark) (PDF)  CP.PHAR.610  April 1, 2025
Sodium Zirconium Cyclosilicate (Lokelma) (PDF) CP.PMN.163 January 1, 2025
Sodium-Glucose Co-Transporter 2 Inhibitors (PDF)  HIM.PA.91  April 1, 2025
Sofosbuvir (Sovaldi) (PDF) HIM.PA.SP2 January 1, 2025
Sofosbuvir-Vepatasvir-Voxilaprevir (Vosevi) (PDF) HIM.PA.SP63 January 1, 2025
Solriamfetol (Sunosi) (PDF) CP.PMN.209 Retire by September 1, 2025
Solriamfetol (Sunosi) (PDF)  CP.PMN.209  September 1, 2025
Sonidegib (Odomzo) (PDF) CP.PHAR.272 Retire by July 1, 2025
Sonidegib (Odomzo) (PDF)  CP.PHAR.272  July 1, 2025
Sorafenib (Nexavar) (PDF) CP.PHAR.69 Retire by September 1, 2025
Sorafenib (Nexavar) (PDF)  CP.PHAR.69  September 1, 2025
Sotatercept (ACE-011) (PDF)  CP.PHAR.657  April 1, 2025
Sotorasib (Lumakras) (PDF) CP.PHAR.549 Retire by July 1, 2025
Sotorasib (Lumakras) (PDF)  CP.PHAR.549  July 1, 2025
Sparsentan (Filspari) (PDF) CP.PHAR.631 Retire by September 1, 2025
Sparsentan (Filspari) (PDF)  CP.PHAR.631  September 1, 2025
Spesolimab-sbzo (Spevigo) (PDF) CP.PHAR.606 Retire by September 1, 2025
Spesolimab-sbzo (Spevigo) (PDF)  CP.PHAR.606  September 1, 2025
Spinosad (Natroba) (PDF) HIM.PA.134 January 1, 2025
Step Therapy Criteria (PDF) HIM.PA.109 Retire by July 1, 2025
Step Therapy Criteria (PDF)  HIM.PA.109  July 1, 2025
Stiripentol (Diacomit) (PDF) CP.PMN.184 January 1, 2025
Sunitinib (Sutent) (PDF) CP.PHAR.73 Retire by September 1, 2025
Sunitinib (Sutent) (PDF)  CP.PHAR.73  September 1, 2025
Sutimlimab-jome (Enjaymo) (PDF) CP.PHAR.503 Retire by July 1, 2025
Sutimlimab-jome (Enjaymo) (PDF)  CP.PHAR.503  July 1, 2025
Suvorexant (Belsomra®) (PDF) CP.PMN.109 January 1, 2025
Suzetrigine (Journavx) (PDF) CP.PMN.301 July 1, 2025
Tadalafil (Adcirca®) (PDF)  CP.PHAR.198  April 1, 2025
Tadalafil BHP - ED (Cialis) (PDF) CP.PMN.132 January 1, 2025
Tafamidis (Vyndaqel, Vyndamax) (PDF)  CP.PHAR.432  July 1, 2025
Tafasitamab-cxix (Monjuvi) (PDF) CP.PHAR.508 March 1, 2024
Talazoparib (Talzenna)(PDF)  CP.PHAR.409  April 1, 2025
Taliglucerase Alfa (Elelyso) (PDF) CP.PHAR.157 Retire by July 1, 2025
Taliglucerase Alfa (Elelyso) (PDF)  CP.PHAR.157  July 1, 2025
Talimogene laherepvec (Imlygic) (PDF) CP.PHAR.542 September 1, 2024
Talquetamab-tgvs (Talvey) (PDF) CP.PHAR.649 March 1, 2025
Tapinarof (Vtama) (PDF)  CP.PMN.283  April 1, 2025
Tarlatamab-dlle (Imdelltra) (PDF) CP.PHAR.685 January 1, 2025
Tasimelteon (Hetlioz) (PDF)  CP.PMN.104  April 1, 2025
Tavaborole (Kerydin®) (PDF)  CP.PMN.105  April 1, 2025
Tazarotene (Arazlo, Fabior, Tazorac) (PDF) CP.PMN.244 January 1, 2025
Tazemetostat (PDF)  CP.PHAR.452  April 1, 2025
Tebentafusp-tebn (Kimmtrak) (PDF) CP.PHAR.575 Retire by July 1, 2025
Tebentafusp-tebn (Kimmtrak) (PDF)  CP.PHAR.575  July 1, 2025
Teclistamab-cqyv (Tecvayli) (PDF)  CP.PHAR.611  April 1, 2025
Tedizolid (Sivextro) (PDF) CP.PMN.62 September 1, 2024
Teduglutide (Gattex) (PDF)  CP.PHAR.114  April 1, 2025
Telotristat Ethyl (Xermelo) (PDF) CP.PHAR.337 Retire by July 1, 2025
Telotristat Ethyl (Xermelo) (PDF)  CP.PHAR.337  July 1, 2025
Temozolomide (Temodar) (PDF) CP.PHAR.77 Retire by September 1, 2025
Temozolomide (Temodar) (PDF)  CP.PHAR.77  September 1, 2025
Temsirolimus (Torisel) (PDF) CP.PHAR.324 January 1, 2025
Tenapanor (Ibsrela, Xphozah) (PDF) CP.PMN.224 September 1, 2025
Tenapanor (Ibsrela, Xphozah) (PDF)  HIM.PA.174  Retire by July 1, 2025
Tenapanor (Ibsrela, Xphozah) (PDF)   HIM.PA.174   July 1, 2025
Tenofovir Alafenamide Fumarate (Vemlidy) (PDF) CP.PMN.268 January 1, 2025
Teplizumab-mzwv (Tzield) (PDF)  CP.PHAR.492  April 1, 2025
Tepotinib (Tepmetko) (PDF) CP.PHAR.530 Retire by July 1, 2025
Tepotinib (Tepmetko) (PDF)  CP.PHAR.530  July 1, 2025
Teprotumumab (Tepezza) (PDF)  CP.PHAR.465  April 1, 2025
Teriflunomide (Aubagio) (PDF) CP.PCH.40 Retire by July 1, 2025
Teriflunomide (Aubagio) (PDF)  CP.PCH.40  July 1, 2025
Teriparatide (Forteo®) (PDF)  CP.PHAR.188  April 1, 2025
Tesamorelin (Egrifta) (PDF) CP.PHAR.109 June 1, 2025
Testosterone (Androderm) (PDF) HIM.PA.87 Retire by June 1, 2025
Testosterone (Androderm) (PDF)  HIM.PA.87  June 1, 2025
Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF) CP.PHAR.354 Retire by June 1, 2025
Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF)   CP.PHAR.354  June 1, 2025
Tetrabenazine (Xenazine) (PDF) CP.PHAR.92 Retire by July 1, 2025
Tetrabenazine (Xenazine) (PDF)  CP.PHAR.92  July 1, 2025
Tezacaftor-Ivacaftor (Symdeko) (PDF) CP.PHAR.377 January 1, 2025
Tezepelumab-ekko (Tezspire) (PDF) CP.PHAR.576 May 1, 2024
Thalidomide (Thalomid) (PDF) CP.PHAR.78 Retire by September 1, 2025
Thalidomide (Thalomid) (PDF)  CP.PHAR.78  September 1, 2025
Thioguanine (Tabloid) (PDF) CP.PHAR.437 January 1, 2025
Thyrotropin alfa (Thyrogen) (PDF) CP.PHAR.95 September 1, 2024
Timothy grass pollen allergen extract (Grastek®) (PDF) CP.PMN.84 January 1, 2025
Tiopronin Delayed-Release (Thiola EC) (PDF) CP.PCH.50 Retire by July 1, 2025
Tiopronin Delayed-Release (Thiola EC) (PDF)  CP.PCH.50  July 1, 2025
Tiopronin Delayed-Release (Thiola EC) (PDF)  CP.PHAR.725 July 1, 2025
Tirzepatide (Zepbound) (PDF) CP.PMN.298 Retire by September 1, 2025
Tirzepatide (Zepbound) (PDF)  CP.PMN.298  September 1, 2025
Tisagenlecleucel (Kymriah) (PDF) CP.PHAR.361 Retire by June 1, 2025
Tisagenlecleucel (Kymriah) (PDF)  CP.PHAR.361  June 1, 2025
Tislelizumab-jsgr (Tevimbra) (PDF)  CP.PHAR.687  June 1, 2025
Tisotumab Vedotin-tftv (Tivdak) (PDF) CP.PHAR.561 March 1, 2025
Tivozanib (Fotivda) (PDF) CP.PHAR.538 Retire by July 1, 2025
Tivozanib (Fotivda) (PDF)  CP.PHAR.538  July 1, 2025
Tobramycin (PDF) CP.PHAR.211 January 1, 2025
Tofersen (Qalsody) (PDF) CP.PHAR.591 January1, 2025
Tolvaptan (Jynarque) (PDF) CP.PHAR.27 January 1, 2025
Topical Acne Treatment (PDF) HIM.PA.71 January 1, 2025
Topical Immunomodulators (PDF)  CP.PMN.107  April 1, 2025
Topiramate ER (Qudexy XR, Trokendi XR (PDF) CP.PMN.281 January 1, 2025
Topotecan (Hycamtin) (PDF) CP.PHAR.64 Retire by July 1, 2025
Topotecan (Hycamtin) (PDF)  CP.PHAR.64  July 1, 2025
Toripalimab (Loqtorzi) (PDF)  CP.PHAR.668  April 1, 2025
Tovorafenib (Ojemda) (PDF) CP.PHAR.686 January 1, 2025
Trabectedin (Yondelis) (PDF)  CP.PHAR.204  April 1, 2025
Tralokinumab-ldrm (Adbry) (PDF) CP.PHAR.577 Retire by July 1, 2025
Tralokinumab-ldrm (Adbry) (PDF)  CP.PHAR.577  July 1, 2025
Trametinib (Mekinist) (PDF) CP.PHAR.240 Retire by July 1, 2025
Trametinib (Mekinist) (PDF)  CP.PHAR.240  July 1, 2025
Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (PDF) CP.PHAR.228 Retire by July 1, 2025
Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (PDF)   CP.PHAR.228  July 1, 2025
Travoprost (iDose TR) (PDF)  CP.PHAR.672  April 1, 2025
Tremelimumab-actl (Imjudo) (PDF) CP.PHAR.612 Retire by June 1, 2025
Tremelimumab-actl (Imjudo) (PDF)  CP.PHAR.612  June 1, 2025
Treprostinil (Orenitram®, Remodulin®, Tyvaso®) (PDF)  CP.PHAR.199  April 1, 2025
Triamcinolone ER Injection (Zilretta) (PDF) CP.PHAR.371 Retire by June 1, 2025
Triamcinolone ER Injection (Zilretta) (PDF)  CP.PHAR.371  June 1, 2025
Triclabendazole (Egaten) (PDF) CP.PMN.207 January 1, 2025
Trientine (Syprine) (PDF) CP.PHAR.438 January 1, 2025
Trifarotene (Aklief) (PDF)  CP.PMN.225  April 1, 2025
Trifluridine/Tipiracil (Lonsurf) (PDF) CP.PHAR.383 January 1, 2025
Triheptanoin (Dojolvi) (PDF) CP.PHAR.509 January 1, 2025
Triptorelin Pamoate (Trelstar, Triptodur) (PDF) CP.PHAR.175 Retire by June 1, 2025
Triptorelin Pamoate (Trelstar, Triptodur) (PDF)  CP.PHAR.175  June 1, 2025
Trofinetide (Daybue) (PDF) CP.PHAR.600 Retire by July 1, 2025
Trofinetide (Daybue) (PDF)  CP.PHAR.600  July 1, 2025
Tucatinib (Tukysa) (PDF) CP.PHAR.497 January 1, 2025
Ublituximab-xiiy (Briumvi) (PDF) CP.PHAR.621 Retire by July 1, 2025
Ublituximab-xiiy (Briumvi) (PDF)  CP.PHAR.621  July 1, 2025
Ulcer Therapy Combinations (Omeclamox Pak, Pylera, Talicia)(PDF) CP.PMN.277 Retire by September 1, 2025
Ulcer Therapy Products (PDF)  CP.PMN.277  September 1, 2025
Umbralisib (Ukoniq) (PDF) CP.PHAR.531 Retire by July 1, 2025
Umbralisib (Ukoniq) (PDF)  CP.PHAR.531  July 1, 2025
Uridine acetate (Vistogard) (PDF) HIM.PA.SP55 January 1, 2025
Vadadustat (Vafseo) (PDF) CP.PHAR.677 Retire by September 1, 2025
Vadadustat (Vafseo) (PDF)  CP.PHAR.677  September 1, 2025
Valbenazine (Ingrezza) (PDF) CP.PCH.48 Retire by July 1, 2025
Valbenazine (Ingrezza) (PDF)  CP.PCH.48  July 1, 2025
Valganciclovir (Valcyte) (PDF)  CP.PCH.06  April 1, 2025
Valoctocogene Roxaparvovec-rvox (Roctavian) (PDF)   CP.PHAR.466   May 1, 2025
Valrubicin (Valstar) (PDF) CP.PHAR.439 March 1, 2025
Vamorolone (Agamree) (PDF)  CP.PHAR.659  April 1, 2025
Vandetanib (Caprelsa®) (PDF)  CP.PHAR.80  April 1, 2025
Vanzacaftor/Tezacaftor/Deutivacaftor (Alyftrek) (PDF) CP.PHAR.700 July 1, 2025
Varenicline (Tyrvaya) (PDF)  CP.PMN.273  April 1, 2025
Velaglucerase Alfa (VPRIV) (PDF) CP.PHAR.163 Retire by July 1, 2025
Velaglucerase Alfa (VPRIV) (PDF)  CP.PHAR.163  July 1, 2025
Velmanase Alfa-tycv (Lamzede) (PDF) CP.PHAR.601 Retire by July 1, 2025
Velmanase Alfa-tycv (Lamzede) (PDF)  CP.PHAR.601  July 1, 2025
Velpatasvir (Epclusa) (PDF) HIM.PA.SP1 January 1, 2025
Vemurafenib (Zelboraf®) (PDF) CP.PHAR.91 Retire by June 1, 2025
Vemurafenib (Zelboraf®) (PDF)  CP.PHAR.91  June 1, 2025
Venetoclax (Venclexta) (PDF) CP.PHAR.129 January 1, 2025
Verteporfin (Visudyne) (PDF)  CP.PHAR.187  April 1, 2025
Vestronidase Alfa-vjbk (Mepsevii) (PDF) CP.PHAR.374 Retire by July 1, 2025
Vestronidase Alfa-vjbk (Mepsevii) (PDF)  CP.PHAR.374  July 1, 2025
Vigabatrin (Sabril) (PDF) CP.PHAR.169 January 1, 2025
Viloxazine (Qelbree) (PDF) CP.PMN.264 Retire by July 1, 2025
Viloxazine (Qelbree) (PDF)  CP.PMN.264  July 1, 2025
Viltolarsen (Viltepso) (PDF)  CP.PHAR.484  April 1, 2025
Vimseltinib (Romvimza) (PDF) CP.PHAR.726 July 1, 2025
Vismodegib (Erivedge) (PDF) CP.PHAR.273 Retire by July 1, 2025
Vismodegib (Erivedge) (PDF)  CP.PHAR.273  July 1, 2025
Voclosporin (Lupkynis) (PDF) CP.PHAR.504 Retire by July 1, 2025
Voclosporin (Lupkynis) (PDF)  CP.PHAR.504  July 1, 2025
Vorapaxar (Zontivity) (PDF)  HIM.PA.146  April 1, 2025
Vorasidenib (Voranigo) (PDF) CP.PHAR.699 January 1, 2025
Voretigene Neparvovec-rzyl (Luxturna) (PDF)  CP.PHAR.372  April 1, 2025
Vorinostat (Zolinza) (PDF) CP.PHAR.83 January 1, 2025
Vortioxetine (Trintellix®) (PDF) CP.PMN.65 January 1, 2025
Vosoritide (Voxzogo) (PDF) CP.PHAR.525 April 1, 2025
Voxelotor (Oxbryta) (PDF)  CP.PHAR.451  April 1, 2025
Vutrisiran (Amvuttra) CP.PHAR.550 Retire by July 1, 2025
Vutrisiran (Amvuttra)  CP.PHAR.550  July 1, 2025
Xanomeline-trospium chloride (Cobenfy) CP.PMN.299 April 1, 2025
Zanidatamab-hrii (Ziihera) (PDF) CP.PHAR.709 June 1, 2025
Zanubrutinib (Brukinsa) (PDF) CP.PHAR.467 Retire by June 1, 2025
Zanubrutinib (Brukinsa) (PDF)  CP.PHAR.467  June 1, 2025
Zavegepant (Zavzpret) (PDF) CP.PHAR.630 March 1, 2025
Zenocutuzumab-zbco (Bizengri) (PDF) CP.PHAR.713 April 1, 2025
Zilucoplan (RA101495) (PDF) CP.PHAR.616 Retire by June 1, 2025
Zilucoplan (RA101495) (PDF)  CP.PHAR.616  June 1, 2025
Ziv-aflibercept (Zaltrap) (PDF) CP.PHAR.325 January 1, 2025
Zolbetuximab-clzb (Vyloy) (PDF) CP.PHAR.705 June 1, 2025
Zoledronic Acid (Reclast) (PDF) CP.PHAR.59 Retire by June 1, 2025
Zoledronic Acid (Reclast) (PDF)  CP.PHAR.59  June 1, 2025
Zuranolone (Zurzuvae) (PDF) CP.PHAR.650 Retire by July 1, 2025
Zuranolone (Zurzuvae) (PDF)  CP.PHAR.650  July 1, 2025